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Articular cartilage damage is a persistent and increasing problem with the aging population, 
and treatments to achieve biological repair remain a challenge. The lack of efficient modalities of 
treatments has prompted research into tissue engineering (TE). TE approaches are a promising 
strategy for improving the rate of repair of articular cartilage lesions by combining cells, 
biomaterials and microenvironmental factors. The work developed at this thesis was aimed to study 
the potential of nanostructured scaffolds based on layer-by-layer (LbL) methodology to be used in 
articular cartilage TE. The polyelectrolytes used for producing these structures were two 
polysaccharides: chitosan (polycation) and chondroitin sulphate (polyanion). These polyelectrolytes 
were chosen due to its biocompatibility and positive influence on cartilage. 
The sequential combination of these polyelectrolytes led to a decrease in frequency and 
increase in dissipation as seen using quartz microbalance (QCM), indicating the development of a 
multilayered film. For the proof of concept, biological assays were first performed in multilayered 
surfaces with bovine chondrocytes (bch). No cytotoxic effects of the film were found. Thus, the 
formation of a nanostructured film was transposed to a three-dimensional (3D) level combining LbL 
and leaching of spherical sacrificial templates. The homogenous distribution of polysaccharides in 
the scaffolds was confirmed by Fourier transformed infrared spectroscopy (FTIR). Morphological 
analysis of the scaffolds was based on scanning electron microscope (SEM), optical microscopy, 
and histology. The results showed a high porosity, which leads to swollen structure when immersed 
in phosphate buffered saline (PBS). The enzymatic degradation tests, using PBS and enzymatic 
solution with lysozyme and hyaluronidase, showed that the scaffold has a gradual degradation, and 
as expected the rate of degradation was higher in the enzymatic solution. Mechanical properties of 
the scaffold were evaluated using dynamic mechanical analysis (DMA). The results revealed that 
scaffold exhibit viscoelastic behaviour which corroborates the results obtained at QCM. 
The applicability of the nanostructured scaffold for cartilage was evaluated in cellular assays 
with bch and human mesenchymal cells (hMSCs). Tests of cell viability, SEM and quantification of 
DNA revealed that scaffolds promote cell adhesion and proliferation. Differentiation studies 
demonstrated the production of glycosaminoglycans (GAGs) by both cells. These results confirmed 
the maintenance of phenotype of bch and the chondrogenic differentiation of hMSCs. Thus, we 
believe the scaffolds developed may have potential use in cartilage TE approaches. 
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Os danos da cartilagem articular são um problema persistente e crescente com o 
envelhecimento da população, pelo que os tratamentos para obter a reparação biológica 
continuam a ser um desafio. A falta de tratamentos eficientes impulsionou a investigação de 
estratégias de engenharia de Tecidos (TE), as quais são estratégias promissoras para melhorar a 
taxa de reparação de lesões da cartilagem articular, combinando células, biomateriais e factores 
microambientais. O trabalho desenvolvido nesta tese teve como objectivo estudar o potencial de 
“scaffolds” nanoestruturados baseados na metodologia de “layer-by-layer” (LbL) para estratégias 
de TE da cartilagem articular. Os materiais utilizados para a produção destas estruturas foram dois 
polissacarídeos: o quitosano (policatião) e o sulfato de condroítina (polianião). Estes foram 
seleccionados devido à sua biocompatibilidade e influência positiva na cartilagem. 
A combinação sequencial destes polielectrólitos leva a uma diminuição da frequência e 
aumento da dissipação na microbalança de quartzo (QCM), indicando o desenvolvimento de um 
filme com multicamadas. Para comprovar a aplicabilidade destas estruturas, primeiramente foram 
realizados ensaios biológicos em superfícies com multicamadas, utilizando condrócitos bovinos 
(bch). O filme produzido não apresentou qualquer efeito citotóxico. Assim, a formação de um filme 
nanoestruturado foi transposta para o nível tridimensional (3D) combinando LbL com lixiviação de 
partículas de sacrifício esféricas. A presença dos polissacarídeos nos “scaffolds” foi confirmada 
pela espectroscopia de infravermelhos por transformadas de Fourier (FTIR). A análise morfológica 
dos “scaffolds” foi baseada em microscopia electrónica de varrimento (SEM), microscopia óptica, 
bem como cortes histológicos. Os resultados obtidos demonstraram uma elevada porosidade, o que 
leva à dilatação da estrutura quando imersa em tampão fosfato salino (PBS). Os testes de 
degradação enzimática realizados, usando PBS e uma solução enzimática composta por lisozima e 
hialuronidase, demonstraram que a degradação dos “scaffolds” ocorreu de forma gradual e tal como 
esperado foi mais acentuada na solução enzimática. As propriedades mecânicas dos “scaffolds” 
foram avaliadas usando análise dinâmica mecânica (DMA). Os resultados revelaram que os 
“scaffolds” exibem um comportamento viscoelástico o que corrobora os resultados obtidos na QCM. 
A aplicabilidade destas estruturas para a cartilagem avaliou-se em ensaios celulares com bch 
e células humanas mesenquimais (hMSCs). Os testes de viabilidade celular, SEM e quantificação 
de DNA revelaram que os “scaffolds” promovem a adesão celular e proliferação. Estudos de 
diferenciação demonstraram a produção de glucosaminoglicanos (GAGs) de ambas as células. 
Estes resultados confirmam a manutenção de fenótipo dos bch e a diferenciação condrogénica de 
hMSCs. Desta forma, acreditamos que os “scaffolds” desenvolvidos terão uma potencial utilização 
em estratégias de TE para a cartilagem. 
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Chapter I 
Chapter I -  General Introduction 
I-1. MOTIVATION AND OUTLINE 
Every year millions of people suffer from cartilage damage which is normally associated with 
sports and progressive ageing [1-3]. Owing to specific properties of cartilage, such as low capacity 
of self-repair, available treatments are not completely successful, so new challenges are required 
[4, 5]. The ideal cartilage treatment would provide the integration of hyaline cartilage with the 
surrounding tissue, would also reproduce the unique zonal architecture of cartilage, would be cost-
effective, and would be accomplished with one surgery. Several cartilage regeneration techniques 
are available and may satisfy many of the characteristics of an ideal cartilage repair method. 
However, the future of cartilage repair seems to be intimately associated with tissue engineering 
(TE) approaches, such as various types of scaffolds, has been demonstrated to own promising 
therapeutic advantages in restoring both the structure and function of the damaged articular 
cartilage [6, 7]. Thus, besides some promising results, new approaches are still need to be 
clinically accepted. 
The goal of this work is to process three-dimensional (3D) porous structures based on layer-
by-layer (LbL) methodology for cartilage TE. The polyelectrolytes selected were chitosan, natural 
abundant, and chondroitin sulphate present in articular cartilage. Chitosan was chosen due to its 
cationic nature that allows the interactions with anionic species, such as glucosaminoglycans 
(GAGs). The choice of chondroitin sulphate was related with its highly negative charge density 
which together with gives rises to the compressive behaviour of cartilage. 
Structures based on chitosan and chondroitin sulphate share the advantage of these two 
polysaccharides and thereby the hypothesis of this work is the positive influence of this 
combination in structured based on LbL for cartilage TE applications. 
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I-2. CARTILAGE TISSUE ORGANIZATION 
Cartilage is a connective tissue that comprises most of the embryonic skeleton [8, 9]. Three 
different types of cartilage have been distinguished based on their histological and biomechanical 
properties: fibrous, elastic and hyaline cartilage[8]. The most prevalent type is hyaline cartilage that 
covers articulating surface and protects against the damage due to repetitive load and friction 
associated with joint movement [10, 11]. Articular cartilage and nasal septal cartilage are examples 
of hyaline cartilage [8]. 
Articular cartilage is an avascular, aneural, alymphatic, anisotropic and acellular (low amount 
of chondrocytes) tissue [2, 12]. This tissue is mainly composed of fluid, comprising up to 80 % of 
the total weight, while solid matrix contribute only with 20 % [13-15]. The fluid content is composed 
by water, gases, metabolites and a large amount of cations to balance the negatively charge GAGs 
in the extracellular matrix (ECM). The solid matrix is mostly composed by collagen type II fibrils, 
smaller amount of type IX, X, XI, V and VI collagen molecules, noncollagenous proteins 
(glicoproteins) and proteoglycans molecules [13, 15, 16]. Proteoglycans are large molecules 
composed of a protein core with polysaccharide side chains attached. The primary proteoglycan in 
articular cartilage is aggrecan which consist of a core protein that is heavily glycosylated with 
negatively charge GAGs, like chondroitin sulphate and keratin sulphate. Aggrecan molecules have 
the ability to interact with hyaluronic acid to form large proteoglycans aggregates via link proteins 
[5, 15, 17]. As a result, the proteoglycans network can be thought as a mesh that is interlaced 
within the more organized collagen structure. The collagen structure gives tissue tensile strength 
and hinders expansion of the aggrecan molecules [17]. Other proteoglycans essential for articular 
cartilage are: biglycans, decorin and fibromodulin [1]. Glicoproteins have a small amount of 
oligosaccharide associated with protein core. This polypeptide is responsible to stabilize the ECM 
matrix and aid in chondrocytes matrix interaction [8, 15].  
In articular cartilage four zones can be distinguished by differences in water and proteoglycans 
concentrations, gene expression, levels of oxygen, cell size, cell shape, metabolic activity, collagen 
fibril diameter and orientation (Figure I-1)[6, 18]. The first zone is the superficial that has two 
distinct layers: an acellular sheet of predominantly collagen fibres and a second layer composed of 
flattened chondrocytes. This zone plays important role for compressive strength of the tissue and 
possibly in isolation of cartilage from immune systems. The second zone is the middle or 
transitional that is composed of spherical chondrocytes randomly oriented on collagen. The third 
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zone is the deep or radial zone that has the largest diameter collagen fibrils, the higher 
concentration of proteoglycans and the least concentration of water. The last zone (calcified) is a 
zone of mineralized tissue, hypertrophic and with circular chondrocytes. This zone lies closest to 
the subchondral bone and act as a transition from soft hyaline cartilage to bone [15, 19]. 
 
Figure I-1: Zonal organization in normal articular cartilage: superficial zone (SZ), middle zone 
(MZ), Deep zone (DZ), and Calcified zone (CZ) bellow which is the subchondral bone 
SB). Each zone is distinct in cell morphology (A), GAGs distribution (B), Collagen 
organization (C) and changes in oxygen levels (D)[ adapted from [6, 18]]. 
I-3. ARTICULAR CARTILAGE ASSOCIATED DISEASES  
Traumatic injury and age-related degenerative diseases associated with cartilage are one of 
the most common health problems worldwide [20, 21]. Age-related diseases occur due to changes 
in the composition of ECM and organization of chondrocytes. With increasing of age there are 
changes in the zonal distribution of chondrocytes and as result the deeper layers have an 
increased number of cells when compared with the superficial layers. Other change is a decrease 
in the hydration of the matrix with a corresponding increase in compressive stiffness. The size of 
proteoglycans aggregates also decreases with the age [1]. 
The poor regeneration of adult articular cartilage is intrinsically associated with the limited 
number of chondrocytes, reduced repairs elements, absence of blood supply and innervations [22, 
23]. In contrast to the adult cartilage, young cartilage has capacity to accelerate synthesis of ECM. 
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Spontaneous repair in adult cartilage usually results in primarily fibrous tissue at the superficial 
layers and fibrocartilage (mechanically and chemically inferior to hyaline cartilage). These repair 
tissues are unable to withstand the higher compressive loads during sports practice or even normal 
gaits and the predilection for the development of degeneration diseases (e.g. osteoarthritis) [14, 
24, 25]. 
There are three main types of articular cartilage injury: matrix disruption, osteochondral or full 
thickness defects and chondral or partial thickness defects [26, 27]. Matrix disruption occurs from 
blunt trauma or age related matrix and it is responsible for ECM damaged. Full-thickness defects 
extend through the cartilage layer and penetrate the subchondral bone. As a result, the defects are 
filled within a fibrin clot. On the other hand, partial thickness defects do not penetrate the 
subchondral bone and immediately following the injury nearby cells begin to proliferate. This type of 
defect is not easily repaired as the full thickness defects because spontaneous repair is only achieved 
when the defects penetrates the subchondral bones, probably triggering a response from the 
mesenchymal stem cells (MSCs) presents in the marrow (Figure I-2) [14, 27, 28]. 
 
Figure I-2: Comparison between partial thickness defects and full thickness defects [28]. 
I-4. ARTICULAR CARTILAGE REPAIR THERAPIES 
Millions of people require treatment to repair damaged cartilage due to limitation of its natural 
self-repair [29]. The therapies for articular cartilage defects can be divided into two major 
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categories: conservative treatments and surgical procedures. The conservative treatments include 
physical therapies (e.g.: ice, supply of orthothesis) and/or drug administration. Nevertheless, these 
treatments only can modify and improve symptoms nevertheless none of these can heal cartilage 
defects. Conversely, the surgical procedures can reconstruct the surface of articular cartilage and 
there are several different types available. Surgical procedures include arthroscopy techniques 
(e.g.: bone marrow stimulating procedure, osteotomy, chondral shaving, debridement, lavage, 
abrasion arthoplasty, osteochondral drilling, microfracture, total joint arthoplasty, distraction of 
joints) and procedures that follow autogenic and allogenic tissue transplantation principles 
(osteochondral transplantation- mosaicplasty, perichondral / periosteal grafting) [2, 30, 31]. 
A wide range of clinical options emerged to repair focal lesions and damage to the articular 
cartilage. These approaches reduce the pain increase the immobility but present a limited extent 
and a short-term period. Thus, TE strategies are a significant clinical option in the treatment of 
damaged or diseased cartilage [13, 15, 32]. The principles of TE rely on the use of cells, 
biomaterials and microenvironmental factors, alone or in combination [33-35]. 
The advantages of TE approaches is the use of scaffolds that can provide the initial structure 
support and retain cells in the defective area which is follow degraded when the cells secrete their 
own ECM. General TE approaches for cartilage repair require some steps that are represented in 
Figure I-3. Briefly, cells are firstly isolated via biopsy from patient and then in order to obtain a large 
amount of cells bi-dimensional (2D) expansion is required. Due to the de-differentiation process 
and cartilage complex three-dimensional (3D) geometry isolated cells are reintroduced into a 3D 
environment, namely scaffold. Bioactive, biomechanical and chemical factors, as well as 
bioreactors, can be used to stimulate cartilage regeneration. Two basic methodologies are normally 
applied in cartilage TE approaches: ex vivo TE and in vivo TE. In ex vivo TE strategy the tissue is 
completely generated in vitro while in vivo TE strategies the construct is implanted with or without 
prior in vitro cultivation and allowed to mature in vivo [4, 36]. 
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Figure I-3: General scheme representing cartilage TE approaches: in ex vivo TE and in vivo TE (adapted 
from [36]). 
I-5. CELL SOURCE 
The optimal source for cartilage TE approaches is still being identified. As a result, wide 
ranges of cells have been already tested such as chondrocytes, stem cells and genetically modified 
cells [4, 7, 37, 38]. Chondrocytes are the most obvious choice, because they are found in native 
cartilage and are responsible for secretion of the ECM. The sources normally used for cartilage 
repair are: auricular cartilage, articular cartilage, nasoseptal cartilage and costal cartilage. These 
cells, like the others, reside, proliferate and differentiate inside the body within a complex 3D 
environment. However, in contrast with other cell types, the isolated chondrocytes in 2D culture 
lose their differentiated phenotype [4, 5, 39]. The de-differentiation process is accompanied by 
morphological/cytoskeletal changes, different ECM synthesis and cell surface receptors profile 
(Figure I-4). The de-differentiation process can be limited when chondrocytes are cultured in a 3D 
environment [5, 38]. 
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Figure I-4: Chondrocytes phenotype shift during dedifferentiation [adapted from table [38]]. 
MSCs are a promising strategy for articular cartilage due to their easy availability and 
multilineage differentiation capacity. These cells can differentiate into different cell types when 
stimulated by microenvironmental factors that are the driving motor for its differentiation [4, 5, 39-
46]. The chondrogenic differentiation involves a 3D structure, growth and environmental factors. 
However, MSCs also have some limitations associated with in vitro expansion due to the potential 
loss of differentiation potential. Moreover, other potential obstacles exist, including cellular 
senescence and death, hypertrophy, and graft integration [44]. The most challenging problem in 
cartilage TE using MSCs is the terminal differentiation to hypertrophy, characterized by high levels 
expression of alkaline phosphatase and collagen type X [44]. 
I-6. MICROENVIRONMENTAL FACTORS 
The microenvironmental factors are namely composed of mechanical and signalling molecules 
[47]. The signalling molecules should try to reproduce the natural sequence of signals guiding 
spontaneous tissue repair and cells. These molecules involved the use of bioactive molecules, 
generally represented by growth factors (GFs) and cytokines [48].  
GFs are polypeptides secreted by a wide range of cells and play a role in either stimulating or 
inhibiting transmission of signals. The signals transmitted regulate cellular activities, such as 
migration, differentiation, proliferation and gene expression. These polypeptides elicit cellular action 
by binding to specific cellular receptors present on the surface of target cells that initiate a cascade 
of biological events to stimulate the regenerative process [48-52]. Cytokines are molecules 
secreted by immune cells to act on damaged or infected tissue. For cartilage regenerative process 
it has been shown that there are several essential GFs and cytokines that provide regulatory effects 
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on chondrocytes or stem cells involved in chondrocytes maturation and cartilage formation [50-57]. 
The GFs and cytokines for cartilage applications include: TGF-β superfamily, IGF, FGF, BMP, 
platelet derived growth factor (PDGF), epidermal growth factor (EGF), interleukins (ILs) and tumor 
necrosis factor (TNF-α) (Table I-1). 
Table I-1: Regulatory effects of GFs and cytokines in articular cartilage 
GFs and cytokines Function 
TGF-β 
superfamily 
Increase proteoglycans synthesis (TGF-β1); Prevent ECM degradation (TGF-β1); Induce 
inhibition of matrix metalloproteinase(MMP) (TGF-β1); Stimulate chondrogenic differentiation of 
progenitor cells (TGF-β1), chondrocyte proliferation (TGF-β1) and maturation (TGF-β3); Induce 
chemotaxis of inflammatory cells [36, 50, 58]. 
IGF - 1 
Promote chondrocyte proliferation; Prevent apoptosis; Induce chondrogenic differentiation of 
progenitor cells; Stimulate chondrocyte proliferation; Prevent ECM degradation (inhibition of 
MMP) [36, 48, 59]. 
FGF 
Promote chondrocyte proliferation; Stimulate deoxyribonucleic acid (DNA) and ribonucleic 
acids (RNA) synthesis; Promote ossification; Induce chemotaxis of inflammatory cells; 
Stimulate MMP and matrix degradation; Augment neovascularization [4, 36, 40, 51]. 
BMP 
Stimulate prechondrogenic condensation and differentiation into chondrocytes (BMP-2, 4, 5, 6, 
7); Induce the matrix synthesis (BMP-2, 4, 6, and 7) and sometimes degradation (BMP-2); 
Promote ossification (BMP-2) [4, 36, 40, 51]. 
PDGF 
Up-regulated the number of IL-1 per chondrocytes growth and differentiation of MSCs; 
Stimulate MMP and ECM degradation; Promote ossification [4, 36, 40, 51]. 
EGF Induce chondrocytes proliferation; Induce matrix degradation [51]. 
ILs 
Induce MMP inhibition (IL-4, 6) and stimulation (IL-1 , 17, 18); Induce matrix degradation (IL-
1 , 18) [4, 36, 40, 51]. 
TNF-  Stimulate MMP and matrix degradation [4, 36, 40, 51]. 
 
The mechanical factors applied to cartilage cultured in vitro may affect the synthesis and 
organization of components of articular cartilage. These factors stimuli cellular functions and may 
be transmitted to cells by forces affecting the cellular microenvironment. The mechanical factors 
normally applied are: oxygen tension and mechanical loading (deformation, hydrostatic pressure, 
fluid flow, shear stress and dynamic compression) [4, 5, 56]. 
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I-6.1. Scaffold requirements for cartilage tissue engineering 
Scaffolds provide the 3D environment that guides the differentiation and the development of the 
cartilaginous tissue. Such constructs should be designed with the adequate mechanical and physical-
chemical characteristics, in order to mimic the native ECM structure and function [60-62]. As a result 
a number of requirements are necessary to be full filled and illustrated on Table I-2. 
Table I-2: Scaffolds requirement for TE. 
Scaffold Requirements Biological and material basis 
Porosity 
Promote the integration of cells into the scaffolds which allow them to generate their 
own ECM; Enhance implant fixation; Affect mechanical properties [60, 61, 63]. 
Pore size 
Affect cell infiltration, migration and distribution; Improve ECM deposition and 
distribution [61, 64, 65]. 
Interconnectivity 
Promotes cell migration throughout all the volume of the construct; Influence the 
diffusion of physiological nutrients and gases to cells and the removal of metabolic 
waste from cells [60, 61, 64]. 
Surface characteristics 
(topography, chemistry, 
surface energy or 
wettability) 
Affect protein adsorption and cell adhesion; Increase the interaction with the 
surrounding environment; Control cell migration, phenotype maintenance and 
intracellular signalling; Improve the recruitment of cells and the healing at the tissue-
scaffold interface [66-69]. 
Biocompatibility 
Prevents inflammatory or immunologic reactions that comprise the host tissue; 
Support cell adhesion and proliferation [60, 70]. 
Appropriate mechanical 
properties 
Prevent leakage or extrusion after implantation; Support mechanical loading; Provide 
the correct stress environment for the neo-tissue [71]. 
Structural anisotropy Promotes native anisotropic tissue structure [60, 72]. 
Cell adhesiveness 
Improve cell seeding for delivery and retention of cells; Promote maintenance of 
chondrogenic phenotype [60]. 
Bioactivity Act as delivery vehicles for biologics included: cells, genes, peptides and GFs [73]. 
Controlled degradation 
rate 
Promote new tissue ingrowth and remodelling of the ECM; Match healing of new 
tissue assuring the initial strength of the scaffold [67, 74]. 
Geometry and architecture 
Support 3D tissue growth; Control the morphological of the growing tissue; Support 
cell proliferation and differentiation [75]. 
 
Ideally, scaffold should fulfill, a serie of requirements (Table I-2) to promote matrix synthesis 
and optimal chondrocytes homing. The ability of scaffold to bond and integrate with native tissue is 
critical for obtain an homogeneous and functional repair [76]. 
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Among the scaffolds requirements the porous network is a driving parameter in their design 
because is intimately connected to their mechanical properties (e.g: an increase in porosity results 
in a more flexible structure). The scaffolds should ideally mimic the mechanical properties of the 
native tissue. However this can result in a scaffold with low porosity and a decrease in nutreints 
diffusion, which can lead to possible necrosis. As a result, a balance between mechanical 
properties and porosity must be found.  [67, 70, 76]. 
A wide range of scaffolds were already used, such as hydrogels, sponges, membranes, foams, 
fibrous meshes (microfiber and nanofiber-biomimetic the ECM, agglomerate particles, 
microspheres or composite of these materials [70, 77-83]. For all these scaffolds macro and 
micro-structural properties affect the cell survivor, signaling growth, propagation and reorganization 
[35, 65]. So far none currently available scaffolds fulfills all of the requirements and consequently a 
highly variable effects were already related in the growth, differentiation and maintenance of cells 
[36]. 
I-7. SCAFFOLD PROCESSING TECHNIQUES FOR CARTILAGE APPLICATIONS 
Scaffolds are central element to TE strategies and a wide range of fabrication technologies 
have been developed to prepare them. Manufacturing processes should assure a high level of 
control over macro and micro-structural properties [84-86]. 
The different technologies used in scaffolds production dictates the type of structure and also 
affects some characteristics such as: mechanical properties, degradation behaviour, 
biocompatibility and surface properties [84-86]. The techniques normally used for scaffold 
production in TE approaches are presented in Table I-3 and Table I-4. 
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Table I-3: Overview of techniques to prepare scaffolds for TE 
Technique Characteristics 
Melt based process: 
Compression moulding, 
injection moulding and 
extrusion 
 
Production of complex 3D shapes; High reproducibility; High-
throughput; Difficult to control porosity and pore size; Difficult to 
obtain high porosities and interconnectivities [87, 88]. 
Solvent casting and 
particle leaching 
 
Very simple method; High porous structure; High surface area-to-
volume ratios; Interconnectivity can be prevented; Easily and 
independent control of porosity and pore size; Solvent is often 
toxic and is not always possible to assure total removal [84, 89]. 
Electrospinning 
 
Generate fibers that mimic the nanometer scale of fiber that 
compose ECM; Combine nano and micro fibers; Enhancement 
of surface area; Difficult for cell proliferate towards the interior of 
scaffolds [90, 91]. 
Fiber bonding 
 
Large surface area for control cell attachment; Good 
interconnectivity among pores; Difficult to control porosity; 
Increase the mechanical properties of scaffolds when compared 
with the non-woven technologies [84, 85, 92, 93]. 
Woven fabric: Braiding 
and Knitting. 
 
Insufficient mechanical properties [19, 94, 95]. 
Non- woven fabric 
 
High porosity; Insufficient mechanical properties [19]. 
Precipitation and 
particle aggregation 
 
High adhesion between particles; High interconnectivity; Obtain 
scaffolds with mean pores varying between 100 to 400 µm; 
Possible release of GF; Porosity can be easily controlled by 
microsphere diameter; Low porosity [96]. 
Supercritical fluid 
technology: Gas 
foaming, gas foaming + 
particle leaching and 
phase inversion  
Obtain dry porous structures without residual solvent; High 
porosity; Partially interconnected pores; Highly pure materials 
ideal for medical application; Only few types of polymers can be 
used; Low solubility of proteins in SCO2; Avoid high temperature 
and organic solvent, allowing to incorporate the incorporation of 
bioactive agents [97-99]. 
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Table I-4: Overview of techniques to prepare scaffolds for TE (continuation) 
Technique Characteristics 
Freeze drying 
 
Simplicity of operation; Large porosity (91-95 %); Small median 
pore size (13-35 µm); Usually low interconnectivities; Difficulty 
ensure structural stability and adequate mechanical properties 
after subsequent hydration [100, 101]. 
Membrane lamination 
 
Irregular pore size; Tedious process [102]. 
Hydrocarbon 
templating 
 
Allows incorporation of proteins; Control over interconnectivity 
[103]. 
Layer by layer 
(LbL)methodology 
 
Generally associated with surface modification; Allows a 
production of a porous structure with highly interconnectivity 
[104, 105]. 
Rapid Prototyping and 
its subdivision 
 
More precision than the conventional techniques; Ability to 
produce complex shaped objects; incorporation of GF is possibly; 
Well-defined internal and external architecture; Porosity is low; 
Mechanical properties need to be improved [8, 106]. 
I-7.1. Layer-by-layer methodology 
The design of a thin solid film at the molecular level has been first reported in 20 th century 
and two techniques dominated this field: Langmuir-Blodget (LB) and self-assembled monolayers 
(SAMs). However, both present some drawbacks, which limited their application in biological field 
as represented in Figure I-5 [104]. 
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Figure I-5: Schematic representation of drawbacks associated with LB and SAMs [adapted from 
[104, 107]]. 
A new technology called layer-by-layer, LbL, was developed by Decher and co-workers in 
1992. LbL emerged as a simple technique to build films on a solid substrate with precise control of 
thickness and surface charge. As a result in comparison with LB technique, LbL is more simple 
and faster and result in more stable films while in comparison with SAM allows higher loadings of 
biological interesting species [104, 107-109]. 
LbL consists in alternately deposition of polyanions and polycations or bipolar amphiphlies 
that self-assembled and self-organize on the material surface leading to the formation of 
polyelectrolyte multilayer films (PEMs). The deposition of PEMs by LbL has emerged as promising 
technique because only requires a charged substrate and allows the functionalization of it. The 
substrate can range from planar to non-planar templates, such as colloids or microcapsules [110-
114]. 
The driving forces of this process include electrostatic as well as non-electrostatic interactions, 
namely: hydrophobic interactions, van der Waals forces and charge transfer [115-117]. This 
technique is not only applicable for polyelectrolyte/ polyelectrolyte systems, but it can be expanded 
to almost any type of charged species, including inorganic molecules clusters, nanoparticles, 
nanotubes, nanowires, nanoplates, organic dyes, dendrimers, porphyrins, biological 
polyssacharides, polypeptides, RNA and DNA, proteins and viruses [104]. 
LbL have been applied in various areas including TE such as in biomimetic coatings, drug 
delivery, protein adsorption, bioactive coatings, biosensors and the coating of living cells [104, 117-
124]. 
Thin solid films 
LB 
 Expensive  instrumentation; 
Long fabrication periods; 
Limited  types of molecules 
can be embedded. 
SAMs 
 Low loading of  biological 
components; 
Limited number of substrates; 
Limited stability under 
physiological conditions; 
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I-7.1.1. Parameters 
LbL methodology allow  the production of tuned PEMs by varying several parameters, as 
represented in Table I-5 [114]. 
Table I-5: Examples of parameters varied in LbL technique and their influence on final structure 
of film 
Parameters Influence on final structure 
Decrease of ionic strength 
Decrease of mass deposition, swelling, smoothing and stiffness 
[116, 125]. 
Decrease of molecular weight 
Influence the viscoelastic properties; Increase of the thickness; 
Increase the diffusion [112, 116, 125]. 
Increase of number of layers 
Increase the thickness of the film and mechanical properties [124, 
126]. 
Composition 
Influence physic-chemical, mechanical properties and biological 
properties [104, 114]. 
Increase of charge density Decrease of thickness; Increase the ion paring [112]. 
pH Affect the porosity, roughness and thickness [114, 127]. 
Sterical and thermodynamical 
parameters 
Limited the diffusion ability [117]. 
Strength of polyelectrolytes Decrease the hydration and thickness of layers[128]. 
Hydrophilicity of polyelectrolytes Affect the swelling ability and thickness. 
Increase of ion pairing 
Increase stiffness; Decrease mobility, degradation rate and swelling 
ability [128]. 
Increase of film hydration Increase the delivery of active compounds [117]. 
Cross-link Increase the mechanical properties [129]. 
Terminal layer 
Affect biological properties such as cellular behaviour and the 
surface energy [104, 114, 117]. 
Increase of Temperature The exponential growth becomes dominant [117]. 
Topography: Roughness; Presence of 
microstructures. 
Affect cellular adhesion [130]. 
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LbL normally is used as a technique for surface modification, production of microcapsules and 
reservoirs for loading bioactive molecules. However, in 2011 Praveen et al. developed a technology 
for produced nanostructured 3D constructs combining LbL technology and 3D template leaching 
[105]. This thesis will mainly focus on such methodology in order to produce highly porous aimed 
to be used in cartilage TE. 
I-8. POLYMERIC MATERIAL USED IN ARTICULAR CARTILAGE TISSUE ENGINEERING 
The selection of material for scaffolds still remains a fundamental key for the design and 
development of tissue engineering constructs. A wide variety of materials, both synthetic and 
natural, have been used in cartilage application taking account the need of avoiding any adverse 
foreign host response (Table I-6) [67, 131, 132]. As a result, the scaffold can be natural, synthetic 
or hybrid (natural and synthetic). 
Table I-6: Materials already used for articular cartilage TE 
Categories of 
biomaterials 
Polymers used 
Synthetic polymers 
Carbon fibers [3]; Poly (ethylene glycol) (PEG) [5]; Poly (vinyl alcohol) (PVA) [133]; 
Poly (L-lactic acid) (PLLA) [5, 42]; Poly (D-lactic acid) (PDLA) [5, 42]; Poly (D,L-
lactic acid) (PDLLA) [5, 42]; Poly (butyl acrylate) (PBA) [54]; Poly (methyl 
methacrylate) (PMMA) [134]; Poly (ethyl methacrylate) (PEMA) [42]; 
Poly (ethylene) (PE) [135]; Poly (tetrafluoroethylene) (PTFE) [42]; Poly (ε-
caprolactone) (PCL) [75]; Poly (urethane) (PU) [42]; Poly (N-isopropylacrylamide) 
(PNiPAAM) [4]; Poly (glycol acid) (PGA) [54]; Poly (ethylene glycol/oxide) (PEO); 
Poly (lactic-co-glycolic acid) (PLGA) [42]; Poly (ethylene) (PET) [54]; 
Poly (propylene fumarate) (PFP) [136]; Poly (butylene terephthalate) (PBT) [135]. 
Natural 
polymers 
Protein-based 
materials 
Fibrin [5, 42, 133]; Laminin [5, 42, 133]; Gelatin [5, 42, 133]; Collagen [5, 42, 
133]; Silk fibroin [4]. 
Polysaccharide-
based 
materials 
Hyaluronic acid [42, 137]; Chitosan [138]; Agarose [42, 133]. 
Alginate [42, 133]; Cellulose [42, 133]; chondroitin sulphate [139]; Dermatan 
sulphate [140], Gellam gum [141]. 
Bacterial 
polyesters 
PHA (Poly (hydroxyalkanoate)):Poly (3-hydroxybutyrate-co-3-hydroxyvaluate) 
(PHBV) [142]; Poly (hydroxybutyrate) (PHB) [143]. 
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I-8.1. Synthetic polymers 
Synthetic polymers have been widely used for TE because they are more controllable and 
predictable than naturally derived polymers, whereas chemicals and physicals properties of the 
polymer can be tailored to match specific mechanical and degradation characteristics [4, 48]. 
Moreover, risks like toxicity, immunogenicity and infection are much lower for pure synthetic 
polymers. However, they have a lack of biological cues because these materials do not benefit from 
direct cell-scaffold interactions that could promote the desired cell response. In addition, some 
degradation products may be toxic or elicit an inflammatory response due to their accumulation 
and decrease of local pH derived of acidic products [48, 144]. 
I-8.2. Natural polymers 
The growing interests in natural-based polymers relies on  their economic and environmental 
aspects, as well as biocompatibility, biodegradability, low toxicity, low manufacture costs, low 
disposal costs and renewability [48, 145]. In addition, these polymers offer the advantage of being 
similar to biological macromolecules providing biological signalling, cell adhesion, cell responsive 
degradation and re-modelling [146-149]. Living organisms are able to synthesize natural polymers 
during the growth cycles. The synthesis is typically formed within cells by complexes metabolic 
processes, generally included enzyme-catalysed, chain growth polymerization reactions of activated 
monomers. Natural polymers can be divided into three major classes: polysaccharides, proteins 
and bacterials polyesters, such as PHAs (PHB and PHBV) [34, 145, 148]. 
Polysaccharides derive from virtually any renewable resources, namely wood, plants, animals 
and microorganisms. Biochemically, these materials consist of monosaccharides linked by O-
glycosidic linkages [34, 145, 148]. They may be linear or branched, and may have single or mixed 
linkage between monosaccharides units. Differences between the monosaccharides, linkage types, 
chain shapes and molecular weight, dictate their physical properties, such as solubility, gelation 
capability and surface properties. The interest of polysaccharides as a material used for TE are 
related with non-toxicity, renewability, water solubility, stability to pH variations and their capacity to 
be chemical modified in order to achieve high swelling in water. However, they have low 
mechanical, thermal and chemical stability. They also cannot be processed alone using melt-base 
techniques and are usually shaped by solvent-based methodologies. Natural-based polymers may 
Chapter I – General Introduction 
 
19 
be combined with synthetic polymers to be processed using extrusion, injection moulding and 
compression moulding [34, 145, 146, 148, 150]. 
I-8.2.1. Chitosan 
Among naturally derived polymers, chitin is one of the most abundant natural polymer that 
can be found in shells from crustaceous, cuticles insects and cell walls of fungi. The most 
important derivative of it is chitosan [151, 152]. Chitosan has been found as an excellent 
candidate in a broad spectrum of TE applications due to its characteristics, namely, 
biocompatibility, biodegradability, non-toxicity, remarkable affinity to proteins, along antitumoral, 
antibacterial, anticholesteremic, fungistatic and haemostatic properties [153-155]. This 
polysaccharide is obtained by a partial deacetylation of chitin under alkaline treatment 
(concentrated sodium hydroxide - NaOH) or by enzymatic hydrolysis in the presence of chitin 
deacetylase (Figure I-6) [138, 153, 155]. 
 
Figure I-6: Chemical structure of chitin and chitosan[adapted from [138]. 
Chitosan in solid state is a semicrystalline polymer with a high elastic modulus in the dry state 
owing to the high glass transition temperature [156, 157]. Structurally is a linear copolymer 
composed of glucosamine (deacetylated unit) and N -acetyl glucosamine (acetylated unit) units 
linked by β (1→ 4) glycosidc bonds and it is normally insoluble in aqueous solutions above pH=7. 
However, in dilute acids (pH below 6), the free amine groups are protonated and the molecule 
becomes soluble [158-160]. Generally, chitosan has three types of reactive functional groups, an 
amino group (C [2] position), a primary (C [3] position) and secondary (C [6] position) hydroxyl 
groups. These groups allow modifications, such as covalent ionic or graft copolymerization, which 
is very useful for TE applications [153, 155, 161]. 
The degree of deacetylation (DD) measures the ratio between glucosamine and N-acetyl 
glucosamine in polymeric chains. Depending on the source and preparation procedure, chitosan 
molecular weight may range from 300 to over 1000 kDa with a DD from 30 % to 95 % [155, 162]. 
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The DD influences physicochemical properties, such as solubility, crystallinity, biodegradability, 
swelling behaviour and biological properties [155, 162, 163]. The degradation of chitosan in 
human body has been reported to be carried out by enzymatic hydrolysis with lysozyme. Lysozyme 
is a primary enzyme responsible for in vivo degradation of chitosan which appear to target 
acetylated residues [138, 164]. Studies have demonstrated that chitosan and its degraded 
products are involved in the synthesis of the articular components, including chondroitin sulphate, 
dermatan sulphate, hyaluronic acid, keratan sulphate, and type II collagen [165]. The degradation 
kinetic of this material appears to be inversely related to DD, as it occurs for crystallinity [47, 163, 
164]. 
For articular cartilage TE the ideal cell-carrier substance should mimic the natural environment 
in the articular cartilage ECM [166]. Most of the potential of chitosan for this application is its 
structural similarity with cartilage-specific ECM components such as GAGs [47, 138]. Moreover, 
chitosan cationic nature and high charge density in solution allows electrostatic interactions with 
anionic species, such as GAGs and proteoglycans [47, 138, 156]. Consequently, numerous studies 
in vitro and in vivo have been demonstrated a positive influence of chitosan on chondrocyte 
behaviour. In vitro studies developed by Malafaya et al. showed that human adipose derived MSCs 
seeded onto chitosan particles agglomerated scaffolds had a capacity to differentiate the 
chondrogenic lineage [78]. In vivo performance of chitosan-glycerophosphate gels were evaluated 
by Chenite et al. by mixing them with primary culture bovine chondrocytes (bch) and implanting 
subcutaneously in athymic mice. The implant area revealed several areas of remodelling 
chondrocytes secreting a matrix characteristic of normal cartilage [167]. Lu et al. has also 
demonstrated that chitosan solution injected into the knee articular cavity of rats led to significant 
increase in chondrocytes density [168]. Mattioli-Belmonte et al. showed that BMP-7 associated with 
N-dicarboxylmethyl chitosan induces or facilities the repair of articular cartilage lesions in rabbits 
[169]. 
I-8.2.2. Chondroitin sulphate 
Chondroitin sulphate is a linear, complex, sulphated unbranched polysaccharide belonging to 
the class of macromolecules known as GAGs [170-173]. It is composed of repeating dissacharide 
units of D-glucuronic acid and N-acetylgalactosamine linked by β-(13) bonds. Like other natural 
polysaccharides, chondroitin sulphate derives from animal sources by extraction and purification 
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processes [170]. The animal sources generally used are chicken, porcine, bovine and cartilaginous 
fish such as sharks and skate [170, 174]. As a result chondroitin sulphate is a heterogeneous 
polysaccharide in terms of charge densities due to sulphate groups in varying amounts and linked 
in different positions, molecular masses, polydispersivity, chemical properties, biological and 
pharmacological activities [175, 176]. 
 
Figure I-7: Structures of disaccharides forming chondroitin sulphate. Different groups on R1, R2 
and R3 give rise to different types of CS: R1=R2=R3=H non-sulphated chondroitin, 
R1=[   
 ]and R2=R3= H chondroitin-4-sulphate; R2=[   
 ]and R1=R3=H chondroitin-
6-sulphate; R2=R3=[   
 ]and R1=H chondroitin-2,6-disulphate; R1=R2=[   
 ]and 
R3=H chondroitin-4,6-disulphate; R1=R3= =[   
 ] and R2=H chondroitin-2,4-
disulphate; R1=R2=R3==[   
 ] trisulphated chondroitin [175]. 
For cartilaginous tissues, this molecule (chondroitin-4-sulphate and chondroitin-6-sulphate) is 
an important structural component [177-180]. The tightly packed and highly charged sulphate 
groups of chondroitin sulphate generate electrostatic repulsion that provides much of the 
resistance of cartilage to compression and also cooperates in the shock absorbing capacity of 
aggrecans [47, 181]. Consequently, this polysaccharide with anionic nature enables efficient 
interaction with cationic molecules to form interesting structures [182, 183]. However, the major 
drawback of chondroitin sulphate is the high solubility in water, which limits its use alone in the 
solid state for biomedical applications, being frequently cross-linked or combined with other 
polymers, such as chitosan, hyaluronic acid, PVA, PLGA, PLLA, PCL, collagen, cellulose and gelatin 
[47, 177, 184-188]  
Chondroitin sulphate is currently used as an ingredient in dietary supplements with the 
ultimate goal of relieving some of the pain and disability of patients with musculoskeletal 
pathologies, namely osteoarthritis [186, 189]. The benefits of chondroitin sulphate for the 
treatment of osteoarthritis are related with the stimulation of ECM production by chondrocytes, 
suppression of inflammatory mediators and inhibition of cartilage degeneration [190]. Thus, due to 
its nature, chondroitin sulphate has been used in the development of supports for cartilage TE 
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applications due to its chondroprotective ability and increased ECM synthesis [47, 191]. A number 
of recent studies have reported that chondroitin sulphate stimulates proliferation and matrix 
component production of seeded chondrocytes in collagen-GAG matrices in vitro [139, 192, 193]. 
Yan et al. reported in vitro and in vivo studies of a tri-copolymer matrix (collagen-chondroitin 
sulphate-chitosan). In vitro studies showed that chondrocytes adhered to the scaffold, where they 
proliferated and secreted ECM, filling the space within the scaffold. In vivo studies performed with 
subcutaneous implantation in nude mice demonstrated a homogeneous cartilaginous tissue similar 
to those of natural cartilage, when chondrocytes were seeded in collagen-chondroitin sulphate-
chitosan matrix after implant of 12 weeks [194]. Collagen-GAG matrices were also used as a 
reservoir to GFs, namely IGF-I, and this combination demonstrate the increase of proteoglycan 
production in vitro.[195]. Fan et al. used PLGA–gelatin-chondroitin sulphate-hyaluronate hybrid 
scaffold and showed their capacity to induce differentiation of MSCs cells [196]. This material was 
also used in LbL methodology as polyanion and according to Gong et al. LbL assembly of 
chondroitin sulphate and collagen on aminolyzed PLLA porous scaffolds enhances their 
chondrogenesis [197]. 
I-8.2.3. Combination of chitosan and chondroitin sulphate 
Several studies reported the combination between chitosan and chondroitin sulphate in 
various areas of TE, such as controlled release of drugs, conventional scaffolds, and surface 
modification with techniques like LbL methodology [47, 198-200]. Chitosan and chondroitin 
sulphate have analogous structures and this suggest that chitosan also can have specific 
interactions with GFs, receptors and adhesion proteins. However chitosan has poor mechanical 
strength limiting its application as biomaterial. Consequently combinations between this material 
and others became recurrent [191, 199, 201]. The combination with chondroitin sulphate occurs 
due to ionic interactions between the positively charged of chitosan and negatively charged of 
chondroitin sulphate. In 1976 this combination was called a film-like complex, due to their 
electrostatic interactions [202]. According to Denuziere et al. chitosan when associated with 
various polyelectrolytes has a protective effect against GAGs hydrolysis by their specific enzymes 
[191, 202]. 
For cartilage TE, the combination of chitosan with other materials, namely GAGs, reveals 
determinant due to the lack of other bioactive ECM components. The use of GAGs enhances the 
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chondrocytes differentiation and tissue formation. Chondroitin sulphate has been reported as 
beneficial to chondrocytes because it has chondroprotective ability and stimulate ECM synthesis 
[191, 201]. As a result the combination between this material and chitosan, according to Yuan et 
al., enhance the hydrophilicity, biological compatibility and mechanical strength [201]. Sechriest et 
al produced a chondroitin sulphate-chitosan support for chondrogenesis where bovine articular 
chondrocytes were seeded. The results show that chondrocytes establish focal adhesions 
maintaining a phenotype of differentiated chondrocytes with collagen type II and proteoglycan 
production [203]. Chen et al. also related that the use of composite chondroitin-6-sulphate-
dermatan sulphate-chitosan scaffolds for cartilage TE is beneficial for ECM production [140]. 
I-9. CONCLUSION AND FUTURE PERSPECTIVES  
Cartilage diseases generally derived from joint and systemic disorders affect millions of people 
worldwide with economic impact in the healthcare system. The scarcity of treatment modalities has 
motivated attempts for the cartilage TE approaches that can meet the functional demands of this 
tissue in vivo [31, 204]. Cartilage TE has key elements like cells, scaffolds and microenvironmental 
factors that can be used together or alone [9, 14, 35]. Each one of these elements is continuously 
being developed to achieve an adequate compromise between known biomaterials chemistry and 
structure as well as cell source, mechanical loadings, bioreactors and stimulation factors [4, 5, 7]. 
Despite the number of patented and applying products for FDA approval, extensive research 
will be needed to determine whether the results can be extended to the human situations. Thus, 
the goal of investigators working on this field is to develop a system with ability to promote the 
production of cartilage tissue and mimics native tissue properties, accelerating the restoration of 
this tissue function and its clinically applicability [7]. This is an ambitious goal, but significant 
progress and important advances have been made in recent years. 
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Chapter II 
Chapter II -  Materials and methods 
The main aim of this Chapter is to describe in more detail the experimental work that was 
employed throughout the thesis. In this Chapter each technique and experimental details used will 
be highlighted. 
II-1. MATERIALS 
Chitosan (CHT) of medium molecular weight (MW 190.000-310.000 Da, 75-85 % degree of 
deacetylation (DD), viscosity 200-800 cps) and chondroitin-4-sulphate (CS) (Mw 50.000 to 
100.000 Da) were purchased from Sigma Aldrich. Before being used chitosan was purified by 
recrystallization. The first step was dissolved it in 1 % (w/v) acetic acid solution and then filtered 
into a Buckner flask under vacuum through porous membranes (Whatman® ashes filter paper, 20-
25 μm). The pH of solution was adjusted to 8 by adding a solution of sodium hydroxide that 
caused flocculation due to deprotonation and insolubility of the polymer at neutral pH. The polymer 
solution was then neutralized until the pH was equal to that of distilled water. Samples were frozen 
at - 80°C and lyophilized. 
The paraffin wax spheres were purchased from Jojoba Desert Whale (Tucson, USA) and then 
modified with polyethylene imine (PEI) (Sigma- Aldrich). 
The glass coverslips with 13 mm (L4097-3) were purchased from Agar Scientific. 
Lysozyme from chicken egg white (lyophilized powder   10000 U/mg stored at 4°C) and 
hyaluronidase from bovine tests (Type VIII, 300 U/mg stored at -20°C) were purchased from 
Sigma- Aldrich. 
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II-2. METHODS 
II-2.1. Layer-by-layer assembly in 2D surfaces 
The CHT/CS polyelectrolytes multilayers (PEMs) were constructed onto glass coverslips. The 
glass coverslips were placed in 70 % (v/v) ethanol during 2 hours and then immersed in 0.15 M 
sodium chloride (NaCl) for 10 minutes. Then the glass coverslips were dried using nitrogen flow. 
For the layer-by-layer (LbL) coating CHT solution at 0.15 % (w/v) was dissolved in a 1 % acetic acid 
with 0.15 M (NaCl). The pH of solution was adjusted at 5.5. CS at the same concentration was 
dissolved in 0.15 M NaCl and the pH of solution was also adjusted to 5.5. 
The multilayered film build-up started by immersing first the substrate in CHT over 10 min 
followed by immersion in 0.15 M NaCl solution during 5 min. Then the coverslips were dipped in 
CS solution for 10 min, followed by immersion in 0.15 M NaCl during 5 min (Figure II-1). After 
these four steps one double layer (dL) had been assembled. The process was repeated until 10 dL. 
 
Figure II-1: Diagram illustrating the sequential step to prepare surfaces coated with chitosan and 
chondroitin sulphate. 1) First glass coverslips were immersed into a polycationic 
solution of chitosan solution. 2) The coverglasses are subsequent immersed in 
washing solution with NaCl. 3) Immersion in polyanionic solution of chondroitin 
sulphate solution. 4) Immersion in NaCl solution. These sequential steps have been 
repeated until reach 10 double layers (dL). 
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II-2.2. Scaffolds production by layer-by-layer 
The PEMs was constructed onto free-packet paraffin spheres previously modified with PEI. 
Paraffin spheres modified with PEI (200 µm) were chosen as porogen and 150 mg of them placed 
into modified cylindrical containers with a porous base. Drop wise addition of polyelectrolytes and 
washing solutions over the top of assembly was done to form 10 dL of CHT and CS. The coated 
structure was placed in dichloromethane (DCM) to leach out the paraffin. After the leaching the 
samples were freeze dried. 
 
Figure II-2: Schematic diagram of the produced scaffolds. A) Paraffin wax spheres coated with 
PEI, B) Addition of polyelectrolytes, C) Leaching with DCM and freeze dried process. 
II-2.3. Physicochemical characterization of scaffolds and surfaces 
II-2.3.1. Build-up Mechanism for film constructed 
The build-up process of the CHT and CS multilayers was followed in situ by quartz crystal 
microbalance (QCM-Dissipation, Q-Sense, Sweden). This technique consists in measuring the 
resonance frequency and dissipation changes (∆f and ∆D, respectively) of quartz crystal induced 
by polyelectrolyte adsorption on the AT cut quartz crystal. This crystal can be excited at its 
fundamental frequency (5 MHz) and at several overtones [1-3]. 
The crystals were cleaned in an ultrasound bath at 30°C using successively acetone, ethanol 
and isopropanol. Adsorption took place at pH 5.5 and at a constant flow rate of 50 μL min-1. The 
polycationic solution (chitosan) was injected standing for 10 min to allow the adsorption 
equilibrium at the crystal surface to be reached. Subsequently, the rinsing step was carried out by 
1 2 3
LbL
Leaching
in DCM
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the injection of 0.15 M NaCl adjusted at pH 5.5 during 10 min. The same procedure was followed 
for the deposition of chondroitin sulphate. The steps were repeated to the desire number of layers. 
The frequency and dissipation were monitored in real time. The thickness of the film was estimated 
using the Voigt model through the Q-Tools Software, from Q-Sense. 
II-2.3.2. Morphology 
II-2.3.2.1. Optical microscope 
The morphology of the scaffolds, after the leaching, was assessed immersing them in DCM, 
using transmitted light of Axioplan Imager Z1 microscope (Zeiss). 
II-2.3.2.2. Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) has been routinely applied for the morphological analysis 
of structures developed for tissue engineering (TE) purposes. In SEM the specimen is scanned 
point by point with an electron beam, and secondary electrons that are emitted by the sample 
surface on irradiation with the electron beam are detected. In this way, a 3-D impression of the 
structures in the sample, or of their surface, respectively, is obtained [4]. 
After the freeze-dried process scaffolds morphology was performed in Philips XL 30 ESEM-FEG 
operated at 15 KV accelerating voltage and 250 x and 1000 x magnifications. Surface morphology 
was also assessed using the same equipment at 7.5 kV accelerating voltage and 250 x 
magnifications. All the samples were coated with a gold sputter (Cressington) for 40 s at a current 
of 40 mA. 
II-2.3.3. Fourier transform infrared spectroscopy 
The Fourier transform infrared spectroscopy (FTIR) is a conventional way to infer about the 
miscibility of polymers via a detailed structural analysis provided by active vibrational transitions. 
This is performed analysing the shifts of the characteristic bands of components. FTIR analysis can 
operate separately in transmission, reflection or attenuated reflection (ATR) mode, however in this 
case the surface has to be flat [5, 6]. FTIR measurements were recorded using an IRPrestige-21 
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spectrophotometer as the average of 34 individual scan over the range 4400 cm-1 to 400 cm-1. The 
samples were combined with potassium bromide (KBr) to produce discs. 
II-2.3.4. Swelling test 
The water uptake ability of the scaffolds with known weight was determined by soaking them 
in phosphate buffered saline solution (PBS, Gibco) at pH=7.4 up to 3 days at 37°C. The swollen 
scaffolds were removed at predetermined time points ( t=15 min, 30 min, 1 h, 2 h, 3 h, 4 h, 5 h, 
1 day, 2 days and 3 days). The excess of water of each scaffold was removed using a filter paper 
(Whatman Pergamyn Paper) and then they were weighted with an analytical balance (Scaltec, 
Germany). The water uptake was calculated using Equation II-1, where Ww and Wd are the weights 
of swollen and dried scaffold, respectively. 
                 
     
  
     
Equation II-1: Determination of water uptake. 
II-2.3.5. Enzymatic Degradation 
The enzymatic degradation test is normally performed to evaluate the degradation rate of the 
scaffolds produced in simulated physiological environments. Scaffolds were placed at 37°C in PBS 
solution (pH=7.4) or at enzymatic solution containing 2 mg/ml of lysozyme and 0.33 mg/ml of 
hyaluronidase (pH=7.4) [7]. PBS and enzymatic solution were changed every third day. At 
predetermined time intervals t=3, 7 and 14 days the scaffolds were washed with distilled water to 
remove the salts. Then the scaffolds were immersed in ethanol 100 % and dried for 1 day at room 
temperature. The percentage of weight loss (WL) was calculated according to the following 
equation (Equation II-2), where Wi and Wf are the weights of dry scaffold and after incubation in 
PBS or enzymatic solution, respectively. 
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Equation II-2: Determination of WL (%) 
II-2.3.6. Mechanical Properties 
Dynamical mechanical analysis (DMA) is common tool used in the laboratory for monitoring 
relaxation events, measurements of elastic modulus and damping factor and the analysis of 
interfacial phenomena, such as in composites and immiscible blends. In this technique, an 
oscillating force is applied to a sample and the material’s response it will be a deformation. The 
deformation is measured as a function of time or/and temperature. From these measurements it 
is possible to calculate the storage modulus (E’) and the loss factor (tan δ) versus time or 
temperature for one or more frequencies [8]. 
For this study, compression tests were carried out by dynamic mechanical analysis (DMA) 
using a Tritec 2000B equipment (Triton Technology, UK) in order to characterize the mechanical 
properties of cylindrical scaffolds in both dry and wet states. The sizes of samples were measured 
using a digital micrometer with precision of 0.001 mm. For the wet state, prior to any 
measurements the scaffolds were immersed in PBS until equilibrium was reached. The 
measurement was carried out at 37°C under full immersion of the sample in liquid bath (PBS) 
placed in a Teflon® reservoir. Experiments were carried out in compression mode following cycles 
of increasing frequency ranging from 0.1 to 15 Hz, with constant strain amplitude of 30 μm. The 
frequency range chosen covers the characteristic timescales of the periodic loads felt by the 
scaffold in vivo (e.g. typically frequency of skeletal movement and passage of blood, among 
others). The high frequency limit used in this study should provide information about the 
viscoelastic properties for the equivalent of short times (e.g. equivalent to a shock or sudden 
impact felt by the construct). Moreover, the frequency range used is within the typical frequency 
interval employed in DMA studies [9]. 
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II-2.4. Cellular assays 
II-2.4.1. Bovine articular chondrocytes and human mesenchymal stem cells 
culture 
Two different cell types were used in this study, the bovine chondrocytes (bch) and human 
mesenchymal stem cells (hMSCs). Bch cells were isolated f by 0.2 % collagenase rom freshly 
collected cartilage of a calf knee .hMSCs were selected by adherence from the bone marrow of 
human donors undergoing total hip replacement. Ethical approval has been obtained from the 
Almelo and Enschede hospital. 
The isolated bch were washed, centrifuged and re-suspended in chondrocytes proliferation 
medium containing dulbecco’s modified eagle medium (DMEM, Invitrogen, USA), fetal bovine 
serum (FBS, 10 %, Sigma-Aldrich), non-essential aminoacids (0.1 mM, Sigma-Aldrich), 
penicillin/streptomycin (100 U/100 μg/mL, Invitrogen), proline (0.4 mM, Sigma-Aldrich) and 
Ascorbic acid 2-phosphate (ASAC, 0.2 mM, Invitrogen) in a humidified atmosphere with 5 % CO2 
and at 37°C. hMSCs were also washed, centrifuged and re-suspended in MSCs proliferation 
medium containing alpha modified eagle’s medium (α-MEM, Invitrogen, USA), fetal bovine serum 
(FBS, 10 % Sigma-Aldrich), penicillin/streptomycin (100 U/100 μg/mL, Invitrogen), Glutamine 
(2 mM, Sigma-Aldrich), basic fibroblast growth factor (bFGF, 1 ng/mL, Sigma Aldrich) and ASAC 
(0.2 mM, Invitrogen) in a humidified atmosphere with 5 % CO2 and at 37°C. bch and hMSCs were 
seeded in tissue culture flasks and the medium was change every third day until cells achieved 
80 % of confluence. bch were used at passage 2 and hMSCs at passage 3. 
Prior to cell seeding scaffolds were sterilized with 70 % (v/v) ethanol overnight and then rinsed 
three times in PBS, whereas surfaces were treated with ultraviolet (UV) light for 10 min to avoid the 
damage of the coating. Scaffolds and flat surfaces were then immersed for 4 hours in the medium 
appropriate for each cell type. For the scaffolds the seeding was performed by applying the cell 
suspension, with a concentration of 0.5x106 cells in 25 μL of medium (per scaffold). For surfaces 
the cell concentration was adjusted to 1.32x104 cells in 25 μL of medium (per surface). 
After cell attachment for 2 hours (37°C in a 5 % CO2), chondrocytes proliferation medium, 
MSCs proliferation medium or differentiation medium (DMEM, 2 mM glutamine (Gibco), 0.2 mM 
ASAC (Invitrogen), 100 μg/mL penicillin/Streptomycin (Invitrogen), 0.4 mM proline (Sigma-
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Aldrich), 100 μg/mL sodium pyruvate (Sigma-Aldrich) and 50 mg/mL insulin-Transferrin-selenite 
(ITS+premix, BD biosciences), 10 ng/mL TGFβ-3 (R&D systems) and 0.1 μM dexamethasone 
(Sigma-Aldrich)) was added. 
II-2.4.2. Cell viability and morphology 
The cell viability and morphology were assessed with live/dead, MTT assay and SEM. The 
scaffolds were cut in half in order to perform live dead and MTT at 1, 3, 14 and 21 days. Scaffolds 
were further observed by SEM. For the surfaces live dead assay was performed at 1, 3, 7, 14 and 
21 days, followed by SEM visualization. Medium was changed every third day to maintain an 
adequate supply of cell nutrients. 
II-2.4.2.1. Live/dead assay 
To perform this assay the medium was aspirated from the scaffolds and surfaces. The 
scaffolds and surfaces were then incubated with ethidium homodimer-1 (4 μM) and calcein-AM 
(2 μM) in PBS for 30 min at 37°C in a 5 % CO2 atmosphere incubator. After 30 min the samples 
were immediately examined in an inverted fluorescent microscope (Nikon Eclipse E600) using 
Fluorescein isothiocyanate (FITC) and Texas Red Filter, as well as the NIS element- F.30 software. 
The live/dead assay pictures obtained with surfaces were used to average the percentage of 
surface area covered with cells. The program used was Image J. 
Calcein-AM is only capable of entering the cell membrane of living cells where it will be cleaved by 
esterases and produces green fluorescence. On the other side, ethidum homodimer-1 is only able to 
enter dead cells and bind to fragmented nucleic acid, emitting a red fluorescence [10]. 
II-2.4.2.2. MTT assay 
The scaffolds were incubated in 900 μL of proliferation medium and 100 μL of MTT solution 
(5 mg/mL) per well for 2 hours at 37°C in 5 % CO2. The MTT assay measures the metabolic 
activity of viable cells, once that  the dissolved MTT can be converted to an insoluble purple 
formazan by dehydrogenase enzymes that catalyse the cleavage of the tetrazolium ring in MTT [11-
14] Images were captured using a stereomicroscope with colour camera (Nikon SMZ-10A) and the 
Qcapture software. 
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II-2.4.2.3. SEM 
Scaffolds and surfaces with cells were fixed in formalin 10 % and dehydrated using serial 
concentrations of ethanol [ 70 %, 80 %, 90 %, 96 % and 100 % (v/v), 30 min in each], before 
preforming critical point drying (Balzers CPD 030). Finally, scaffolds and surfaces were mounted 
and gold sputtered. The analysis was performed in Philips XL 30 ESEM-FEG operated at 7.5-15 kV 
accelerating voltage and 1000 x-2500 x magnification 
II-2.4.3. DNA quantification 
Scaffolds seeded with bch and hMSCS in differentiation medium at 1, 14 and 35 days were 
washed with PBS and frozen at - 80°C before proteinase K (Sigma Aldrich) digestion. Then the 
scaffolds were digested with 1 mg/mL of proteinase K in tris (hydroxymethyl) aminomethane 
ethylenediaminetetraacetic (Tris\EDTA) buffer (pH=7.6) containing 18.5 μg/mL idoacetamide and 
1 μg/mL pepstatin A (Sigma Aldrich) at 56°C for 20 hours. Quantification of total DNA in each 
sample was determined with CyQuant DNA kit according to manufacturer description (Molecular 
probes, Eugene, Orgeon, USA), using a spectrofluorometer (Victor3, Perkin-Elmer, USA) at an 
emission wavelength of 520 nm and an excitation wavelength of 480 nm. 
II-2.4.4. Histology 
Haematoxylin & eosin (H&E) and alcian blue stainings methods were used to analyse cell 
distribution and cartilage tissue formation, respectively. Scaffolds were fixed overnight in 10 % 
formalin, and then dehydrated using sequential ethanol series [70 %, 80 %, 90 %, 96 %, and 100 % 
(v/v), 30 min in each]. Once dehydrated, they were incubated in butanol overnight at 4°C. 
Ultimately, the scaffolds were incubated paraffin overnight at 56°C and then embedded in paraffin. 
Sections with 4.5 μm of thickness were cut using a microtome (MicroM HM355S). After 
deparaffinization with xylene and rehydration using a graded ethanol series [from 100 % to 70 % 
(v/v)], the samples were stained using the automatic stainer (MicroM HMS740). For H&E staining 
samples were stained with haemotoxylin for 1 min and rinse up to 6 min before being stained with 
eosin for 30 s. For alcian blue staining the samples were placed in alcian blue solution (0.5%, 
pH=1) for 30 min and rinsed with tap water or distilled water for 4 min. In the last step nuclear fast 
red was added for 5 min before dehydratation. Slides were assembled with resinous medium and 
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mounted slides were examined under a light of Axioplan Imager Z1 microscope (Zeiss). 
Representative images were captured using a digital camera (AxioCAM MRCE) and Axiovision 
software. Each assay was performed at 1, 14, 21 and 35 days of culture. 
II-3. STATISTICAL ANALYSIS 
The experiences developed were carried out in triplicate otherwise specified. The results were 
presented as mean ± standard deviation (SD). Statistical analysis was performed using one way 
ANOVA analysis followed by Turkey test (Graph Pad Prism 5.0 for Windows). Statistical significance 
was set to p-value (p) <0.05 (*) and p<0.01 (**). 
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ABSTRACT  
Nanostructured 3D constructs combining layer-by-layer technology (LbL) and template leaching 
were processed and evaluated as possible support structures for articular cartilage. Chitosan (CHT) and 
chondroitin sulphate (CS) were used as polyelectrolytes and their ability to form multilayers was verified 
by Quartz crystal microbalance (QCM). The biological performance of 2D flat CHT/CS multilayers was 
first investigated, in which the viability, adhesion, morphology and proliferation of bovine chondrocytes 
(bch) were studied. The polymeric film was found to be non-cytotoxic and allowed the proliferation of 
bch. The technology was transpose to the 3D level by LbL coating followed by leaching of free-packet 
paraffin spheres. The obtained nanostructured 3D constructs has a high porosity and water uptake 
capability of about 300 %. Dynamical mechanical analysis (DMA) showed a clear viscoelastic nature of 
the scaffolds in which the storage modulus (E’) is about one order of magnitude lower in the hydrated 
state when compared with the dry condition. Moreover enzymatic tests demonstrate that the structure 
could lose about 15 % of the initial weight after 15 days. To test the ability of these scaffolds as supports 
for cartilage TE, cellular tests were performed with the culture of bch and human mesenchymal stem 
cells (hMSCs) up to 21 days. SEM analysis, viability tests and DNA quantification showed that cells 
attached, proliferated and were metabolically active. Cartilaginous ECM formation was assessed and 
results showed that matrix production occurred indicating the maintenance of the chondrogenic 
phenotype and the chondrogenic differentiation of hMSCs. 
Keywords: Layer-by-layer, chitosan, chondroitin sulphate, chondrocytes, human mesenchymal 
stem cells, cartilage tissue engineering. 
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III-1. INTRODUCTION 
Articular cartilage is an avascular, alymphatic, aneural, anisotropic tissue with low mitotic and 
limited capacity to regenerate [1, 2]. It is known that due to articular cartilage properties, millions of 
people which suffer from traumatic injuries and degenerative diseases require treatments [3]. 
However, the current treatments present some limitations and fail to produce long-lasting repair, 
leading in some case to fibrocartilage formation instead of hyaline cartilage [4, 5]. 
Tissue Engineering (TE) has appeared as a new methodology which offers advantages when 
compared with current treatments [4, 6, 7]. Scaffolds play an important role in TE strategies 
because they provide the initial structure support, guiding the differentiation and development of 
the cartilaginous tissue [8-10]. Typically native tissues exhibit an hierarchical organization from the 
nano- to the macro-scale levels. The control from the nano-sizes of scaffold offers the possibility of 
develop structures with further capabilities, including the control of cell behaviour at the nano-level, 
the fabrication of hierarchical-organized devices, the inclusion of other functionalities, such as the 
possibility of incorporate bioactive molecules, or tune the mechanical and degradation behaviour of 
the scaffold. In this work we propose the use of bottom-up approaches to produce three-
dimensional (3D) porous scaffolds with a nanostructured organization adequate to support cells 
development in context of articular cartilage. The layer-by-layer (LbL) methodology is a versatile 
technique that permits to fabricate layers nanostructured multilayered films using a variety of 
polyelectrolytes [11-13]. The principle of this technique is based on alternate deposition of 
polyelectrolytes that will self-organize on the material surface [11-14]. The main application of LbL 
is the build-up of polyelectrolytes multilayers (PEMs) onto flat surfaces [11-13]. Just a few works 
reported the use of LbL to fabricate scaffolds. Such technique may be used to coat free-packet 
leachable  spherical templates [15] or to agglomerate beads [16], leading in both cases to porous 
structures. 
A wide range of materials have been explored to cartilage tissue engineering approaches, 
among which polysaccharides based materials [7, 17]. Chitosan (CHT) is obtained by a partial 
deacetylation of chitin that has structural characteristics similar to glycosaminoglycan’s (GAGs) 
[18]. Chondroitin sulphate (CS) is the major GAG component of native cartilage tissue and it is 
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responsible to generate electrostatic repulsion which provides much of the resistance to 
compression, and also cooperate in the shock absorbing capacity of aggrecans [14, 19]. 
The aim of this work is to prepare nanostructured 3D constructs, based on the LbL 
methodology, studying its effect on cartilage TE. For the proof of concept the build-up of CHT/CS 
PEMs onto flat surfaces were firstly characterized using quartz crystal microbalance (QCM) and its 
biological performance evaluated with a primary culture of bovine chondrocytes (bch), that are the 
cells present in the articular cartilage tissue. The biological performance of highly porous 
nanostructured 3D scaffolds was also evaluated using bch and cells with multilineage 
differentiation capacity, human mesenchymal stem cells (hMSCs). The maintenance of 
chondrogenic phenotype and the differentiation of hMSCs were also investigated. 
III-2. MATERIALS AND METHODS 
III-2.1. Materials 
Chitosan (CHT) of medium molecular weight (Mw 190.000 - 310.000 Da, 75 – 85 % Degree of 
deacetylation, viscosity 200 - 800 cps) and chondroitin-4-sulphate (CS) (Mw 50.000 - 100.000 Da) 
were purchased from Sigma Aldrich. Before being used chitosan was purified by recrystallization. 
Paraffin wax spheres with 200 μm were purchased from Jojoba Desert Whale (Tucson, USA) and 
then modified with polyethylene imine (PEI) (Sigma- Aldrich). Glass coverslips with 13 mm (L4097-
3) were purchased from Agar Scientific. Lysozyme from chicken egg white (lyophilized powder 
≈10000 U/mg stored at 4°C) and hyaluronidase from bovine tests (Type VIII, 300 U/mg stored at 
-20°C) were purchased from Sigma- Aldrich. 
III-2.2. Methods 
III-2.2.1. Build-up Mechanism for film constructed 
The build-up process of CHT/CS PEMs was followed in situ by quartz crystal microbalance 
(QCM-Dissipation, Q-Sense, Sweden), using gold coated sensor excited at a fundamental frequency 
of 5 MHz and at seventh overtone (35 MHz). The crystals were cleaned in an ultrasound bath at 
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30°C using successively acetone, ethanol and isopropanol. Adsorption took with a constant flow 
rate of 50 μL min-1. 
A 0.15 % (w/v) CHT solution was prepared in a 1 % acetic acid with 0.15 M NaCl. The pH of 
solution was adjusted at 5.5. CS at the same concentration was dissolved in 0.15 M NaCl and the 
pH of solution was also adjusted to 5.5. The CHT solution was injected standing for 10 min to 
allow the adsorption equilibrium at the crystal surface to be reached. Subsequently, the rinsing 
step was carried out by the injection of 0.15 M NaCl adjusted during 10 min. The same procedure 
was followed for the deposition of CS. The steps were repeated to the desire number of layers. The 
frequency and dissipation were monitored in real time. The thickness of the film was estimated 
using the Voigt model through the Q-Tools Software, from Q-Sense. 
III-2.2.2. LbL assembly in 2D surfaces 
The CHT/CS PEMs were constructed onto glass coverslips. The glass coverslips were placed 
in 70 % (v/v) ethanol during 2 hours and then immersed in 0.15 M sodium chloride (NaCl) for 
10 min. After these two steps the glass coverslips were dried using nitrogen flow. The multilayered 
film build-up started by immersing first the substrate in CHT during 10 min followed by the 
immersion in 0.15 M NaCl solution during 5 min. Then the coverslips were dipped in CS solution for 
10 min, followed by immersion in 0.15 M NaCl over 5 min. These four steps allowed the assembling 
of one double layer (dL). The process was repeated until 10 dL. 
III-2.2.3. Scaffolds production by LbL 
The PEMs was constructed onto free-packet paraffin spheres previously modified with PEI. 
Paraffin spheres modified with PEI were chosen as the porogen and 150 mg of them placed into a 
modified cylindrical container, with a porous base. CHT was used to make the initial coating. Drop 
wise addition of polyelectrolyte solutions and washing solutions over the top of assembly was done 
to form 10 dL of CS and CHT. The coated structure was placed in dichloromethane (DCM) to leach 
out the paraffin. After the leaching the samples were freeze dried. 
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III-2.2.4. Physicochemical characterization 
III-2.2.4.1. Morphology 
The morphology of the scaffolds after the leaching process and immersed in DCM was 
assessed by optical microscopy, using the Axioplan Imager Z1 microscope (Zeiss). Freeze-dried 
scaffolds were also observed by scanning electronic microscopy (SEM), using a Philips XL 30 
ESEM-FEG operated at 15 kV accelerating voltage. Surface morphology of the glass coverslips was 
also performed using the same equipment at 7.5 kV accelerating voltage. All the samples were 
sputtered with a conductive gold layer, using a sputter coater (Cressington) for 40s at a current of 
40 mA. 
III-2.2.4.2. Fourier transform infrared (FTIR) spectroscopy 
FTIR measurements were recorded using an IRPrestige-21 spectrophotometer, by averaging 
34 individual scans over the range 4400 cm-1 to 400 cm-1. The samples were prepared in 
potassium bromide (KBr) discs. 
III-2.2.4.3. Swelling test 
The water uptake ability of the scaffolds with known weight was determined by soaking them in 
phosphate buffered saline solution (PBS, Gibco) at pH=7.4 up to 3 days at 37°C. The swollen scaffolds 
were removed at predetermined time points ( t=15 min, 30 min, 1 h, 2 h, 3 h, 4 h, 5 h, 1 day, 2 days 
and 3 days). After removing the excess of water using a filter paper (Whatman Pergamyn Paper), the 
scaffolds were weighted with an analytical balance (Scaltec, Germany). The water uptake was calculated 
using Equation III-1, where Ww and Wd are the weights of swollen and dried scaffold, respectively. 
              
     
  
     
Equation III-1: Determination of water uptake. 
III-2.2.4.4. Enzymatic Degradation 
The enzymatic degradation test is normally performed to evaluate the degradation profile of 
the scaffolds produced in simulated physiological environments. Scaffolds were placed at 37°C in 
PBS solution (pH=7.4) or at enzymatic solution containing 2 mg/ml of lysozyme and 0.33 mg/ml 
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of hyaluronidase (pH=7.4) [20]. PBS and enzymatic solution were changed every third day [20]. At 
predetermined time intervals t=3, 7 and 14 days the scaffolds were washed with distilled water to 
remove the salts. Then the scaffolds were immersed in ethanol 100 % and dried for 1 day at room 
temperature. The percentage of weight loss (WL) was calculated according to the Equation III-2, where 
Wi and Wf are the weights of dry scaffold and after incubation in PBS or enzymatic solution, respectively. 
   
     
  
     
Equation III-2: Determination of WL (%) 
III-2.2.4.5. Mechanical Test 
Compression tests were carried out by dynamic mechanical analysis (DMA), using a Tritec 
2000B equipment (Triton Technology, UK) to characterize the mechanical properties of cylindrical 
scaffolds in both the dry and wet states. The sizes of the samples were measured using a digital 
micrometer with precision of 0.001 mm. Prior to any measurements in the wet state the scaffolds 
were immersed in PBS until equilibrium was reached. The measurement was carried out at 37 °C 
under full immersion of the sample in liquid bath (PBS) placed in a Teflon® reservoir. Experiments 
were carried out in compression mode following cycles of increasing frequency ranging from 0.1 to 
15 Hz, with constant strain amplitude of 30 μm. The frequency range chosen covers the 
characteristic timescales of the periodic loads felt by the scaffold in vivo (e.g. typical frequency of 
skeletal movement). The high frequency limit used in this study should provide information about 
the viscoelastic properties for the equivalent of short times (e.g. equivalent to a shock or sudden 
impact felt by the construct) [21]. 
III-2.3. Cellular assays 
III-2.3.1. Bovine articular chondrocytes and human mesenchymal stem cells 
culture 
Two different cell types were used in this study: the bovine chondrocytes (bch) and human 
mesenchymal stem cells (hMSCs). Bch cells were isolated by 0.2% collagenase overnight digestion 
from freshly collected cartilage of a calf knee. hMSCs were selected by adherence from the bone 
marrow of human donors undergoing total hip replacement. Ethical approval has been obtained 
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from the Almelo and Enschede hospital. The isolated bch were washed, centrifuged and re-
suspended in chondrocytes proliferation medium containing dulbecco’s modified eagle medium 
(DMEM, Invitrogen, USA), fetal bovine serum (FBS, 10 %, Sigma-Aldrich), non-essential aminoacids 
(0.1 mM, Sigma-Aldrich), penicillin/streptomycin (100 U/100 μg/mL, Invitrogen), proline 
(0.4 mM, Sigma-Aldrich) and Ascorbic acid 2-phosphate (ASAC, 0.2 mM, Invitrogen) in a 
humidified atmosphere with 5 % CO2 and at 37°C. hMSCs were also washed, centrifuged and re-
suspended in MSCs proliferation medium containing alpha modified eagle’s medium (α-MEM, 
Invitrogen, USA), fetal bovine serum (FBS, 10 % Sigma-Aldrich), penicillin/streptomycin 
(100 U/100 μg/mL, Invitrogen), Glutamine (2 mM, Sigma-Aldrich), basic fibroblast growth factor 
(bFGF, 1 ng/mL, Sigma Aldrich) and ASAC (0.2 mM, Invitrogen) in a humidified atmosphere with 
5 % CO2 and at 37°C. bch and hMSCs were seeded in tissue culture flasks and the medium was 
change every third day until cells achieved 80 % of confluence. bch were used at passage 2 and 
hMSCs at passage 3. Prior to cell seeding scaffolds were sterilized with 70 % (v/v) ethanol 
overnight and then rinsed three times in PBS, whereas surfaces were treated with ultraviolet (UV) 
light for 10 min to avoid the damage of the coating. Scaffolds and flat surfaces were then 
immersed for 4 hours in the medium appropriate for each cell type. For the scaffolds the seeding 
was performed by applying the cell suspension, with a concentration of 0.5x106 cells in 25 μL of 
medium (per scaffold). For surfaces the cell concentration was adjusted to 1.32x104 cells in 25 μL 
of medium (per glass coverslips). After cell attachment for 2 hours (37°C in a 5 % CO2), 
chondrocytes proliferation medium, MSCs proliferation medium or differentiation medium (DMEM, 
2 mM glutamine (Gibco), 0.2 mM ASAC (Invitrogen), 100 μg/mL penicillin/Streptomycin 
(Invitrogen), 0.4 mM proline (Sigma-Aldrich), 100 μg/mL sodium pyruvate (Sigma-Aldrich) and 
50 mg/mL insulin-Transferrin-selenite (ITS+premix, BD biosciences), 10 ng/mL TGFβ-3 (R&D 
systems) and 0.1 μM dexamethasone (Sigma-Aldrich)) was added. 
III-2.3.2. Cell viability 
The cell viability and morphology were assessed with live/dead assay, MTT assay and SEM 
analysis. The scaffolds were cut in half in order to perform live/dead and MTT at 1, 3, 14 and 
21 days. Scaffolds were further observed by SEM. For the surfaces live dead assay was performed 
at 1, 3, 7, 14 and 21 days followed by SEM visualization. Medium was changed every third day to 
maintain an adequate supply of cell nutrients. 
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III-2.3.2.1. Live /dead assay 
To perform this assay the proliferation medium was aspirated from the wells where scaffolds 
and surfaces were deposited. The scaffolds and surfaces were then incubated with ethidium 
homodimer-1 (4 μM) and calcein-AM (2 μM) in PBS for 30 min at 37°C in a 5 % CO2 atmosphere 
incubator. After 30 min the samples were immediately examined in an inverted fluorescent 
microscope (Nikon Eclipse E600) using Fluorescein isothiocyanate (FITC) and Texas Red Filter, as 
well as the NIS element-F.30 software. Calcein-AM is only capable of permeating into plasma 
membrane of living cells where it will be cleaved by esterases and produces green fluorescence. 
On the other side, ethidum homodimer-1 is only able to enter dead cells and bind to fragmented 
nucleic acid, emitting a red fluorescence. The live/dead assay pictures were analysed using 
Image J. to average the percentage of the surface area covered with cells. 
III-2.3.2.2. MTT assay 
The scaffolds were incubated in 900 μL of proliferation medium and 100 μL of MTT solution 
(5 mg/mL) per well for 2 h at 37°C in 5 % CO2. The MTT assay measures the metabolic activity of 
viable cells once that dissolved MTT can be converted to an insoluble purple formazan by 
dehydrogenase enzymes that catalyse the cleavage of the tetrazolium ring in MTT. Images were 
captured using a stereomicroscope with colour camera (Nikon SMZ-10A) and the Qcapture software. 
III-2.3.2.3. Scanning electron microscopy observation 
The structures with cells were fixed in formalin 10 % and dehydrated using serial 
concentrations of ethanol [ 70 %, 80 %, 90 %, 96 % and 100 % (v/v), 30 min in each], before 
preforming critical point drying (Balzers CPD 030). The surfaces of the materials were then coated 
with a conductive layer. The SEM observations were performed in a Philips XL 30 ESEM-FEG 
operated at 7.5-15 kV accelerating voltage. 
III-2.3.3. DNA quantification 
Scaffolds seeded with bch and hMSCS in differentiation medium at 1, 14 and 35 days were 
washed with PBS and frozen at - 80°C before proteinase K (Sigma Aldrich) digestion. Then the 
scaffolds were digested with 1 mg/mL of proteinase K in tris (hydroxymethyl) aminomethane 
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ethylenediaminetetraacetic (Tris\EDTA) buffer (pH 7.6) containing 18.5 μg/mL idoacetamide and 
1 μg/mL pepstatin A (Sigma Aldrich) at 56°C for 20 hours. Quantification of total DNA in each 
sample was determined with CyQuant DNA kit according to manufacturer description (Molecular 
probes, Eugene, Orgeon, USA), using a spectrofluorometer (Victor3, Perkin-Elmer, USA) at an 
emission wavelength of 520 nm and an excitation wavelength of 480 nm. 
III-2.3.4. Histology 
Haematoxylin & eosin (H&E) and alcian blue stainings methods were used to analyse cell 
distribution and cartilage tissue formation, respectively.  For histology analysis, scaffolds were fixed 
overnight in 10 % formalin, and then dehydrated using sequential ethanol series [70 %, 80 %, 90 %, 
96 %, and 100 % (v/v), 30 min in each]. Once dehydrated, they were incubated in butanol 
overnight at 4°C and then in a solution of paraffin at 56°C for 12 hours. Sections with 4.5 μm of 
thickness were cut using a microtome (MicroM HM355S). After deparaffinization with xylene and 
rehydration using a graded ethanol series [from 100 % to 70 % (v/v)], the samples were stained 
using an automatic stainer (MicroM HMS740). For H&E staining samples were stained with 
haemotoxylin for 1 min and rinse up to 6 min before being stained with eosin for 30 s. For alcian 
blue staining the samples were placed in alcian blue solution (0.5%, pH=1) for 30 min and rinsed 
with tap water or distilled water for 4 min. In the last step nuclear fast red was added for 5 min 
before dehydratation. Slides were assembled with resinous medium and mounted slides were 
examined under a light of Axioplan Imager Z1 microscope (Zeiss). Representative images were 
captured using a digital camera (AxioCAM MRCE) and treated using Axiovision software. Each 
assay was performed at 1, 14, 21 and 35 days of culture. 
III-3. STATISTICAL ANALYSIS 
The experiences developed were carried out in triplicate otherwise specified. The results were 
presented as mean ± standard deviation (SD). Statistical analysis was performed using one way 
ANOVA analysis followed by Turkey test (Graph Pad Prism 5.0 for Windows). Statistical significance 
was set to p <0.05 (*) and p<0.01 (**). 
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III-4. RESULTS AND DISCUSSION 
III-4.1. Build-up Mechanism for film constructed 
The build-up mechanism of the polymeric multilayered films made of CS and CHT was 
assessed in situ with QCM-D. This technique detects the adsorbed mass of polyelectrolytes and 
measures the viscoelastic properties of the surface [22, 23]. Figure III-1-A shows the build-up of 10 
layers of CHT and CS in terms of variations on normalized frequency, ∆fn/n (where n is the 
frequency overtone) and dissipation, ∆D7. As expected, the normalized frequency decreases with 
each CHT and CS solutions injection, reflecting the increase of mass over the gold sensor. The 
increase of ∆D7 is due to the non-rigid adsorbed layer structure of the deposited film. During the 
washing step that follows the injection of each polyelectrolyte, the change of both ∆f7/7 and ∆D7 
were small relatively to the total frequency variation associated to the adsorption of the respective 
polymer. This indicates a strong association of the layers on the surface of the crystal. 
  
Figure III-1: Build-up monitoring of the CHT/CS polyelectrolyte multilayered using QCM for film 
constructed: A) Normalized frequency (∆f7/7) and dissipation changes (∆D7) obtain 
at 35 MHz, 1) deposition of CHT, 2) washing step and 3) deposition of CS; B) 
Estimated thickness (th) evolution and SEM micrographs of the multilayer surface 
with 10 dL (inset image). 
The combination of ∆f7/7 and ∆D7 gives information about the adsorbed amount and the 
variations of the viscoelastic properties [22, 24, 25]. The thickness (th) of the film was estimated 
using the Voigt Model [26]. Figure III-1-B shows the th variation along the deposition of 10 layers 
[22, 25]. The results revealed a decrease of th from the first layer to the second one, which can be 
explained due to changes in water absorption [27]. The absorption of water occurs owing to the 
presence of some groups in the polysaccharides (hydroxyl, carboxyl and sulphate groups) that 
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interact favourably with water molecules [27]. When the second layer is adsorbed the presence of 
opposite charge leads to electrostatic interactions between them and the counterion-polymer. 
Consequently, water-polymer bonds are disrupted, resulting in an effective decrease of the 
hydrated film th [24, 27, 28]. The trend was observed during the first three pairs of layers. After 
the first three dL, this trend was no longer observed: there was an increase of th with the addition 
of CS. The SEM microphotography of the multilayered surface revealed a homogenous coating 
along the 2D flat surface - see inset image of Figure III-1B. Moreover, the texture of the surface 
presented a rough texture and some granularity, with characteristic sizes around 2 μm. 
The results obtained through QCM measurements and SEM demonstrates that CS can be 
used successfully with CHT to conceive a homogeneous viscoelastic polymeric self-assembled 
coating using the LbL approach. 
III-4.2. Multilayer surface 
Using LbL methodology it is possible the production of surfaces with tuned properties [11-13] 
.In this work, multilayers of chitosan and chondroitin sulphate have been prepared in glass 
coverslips by using the LbL methodology, obtaining assemblies with 10 dL. 
III-4.2.1. Cell behaviour in multilayers  
In order to assess the cell viability in the surfaces, live/dead assay was performed – see 
Figure III-2 A, C, E, G and I. The results showed a large amount of living cells and low number of  
dead cells in any of the time points indicating that the film has no cytotoxic effects. 
The cell adhesion/morphology was also studied using SEM - see micrographs in Figure III-2 B, 
D, F and H. The results revealed that the bch were attached to the surface in the earliest time 
points. Attachment, adhesion and spreading belong to the first phase of cell/material interaction 
and the quality of this stage influence the capacity of cells to proliferate and differentiate itself on 
contact with the implant[29, 30]. With increasing culture time, ECM production also increase and 
cells start to spread out along the surface, losing their round phenotype. After 7 days of culture a 
huge surface area was already covered and consequently a large amount of proliferation occurred. 
At 14 days a cellular confluence was achieved. 
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Figure III-2:  Live/dead assay and SEM micrographs of bch seeded on glass coverslips coated with 
chitosan and chondroitin sulphate at day 1 (A, B), 3 (C, D), 7 (E, F), 14 (G, H) and 21 
(I, J) of culture in proliferation medium.  
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The cell proliferation onto the CHT/CS multilayered film could be also observed in the live/dead 
assay images. The percentage of area coverage with the cells was measured using the 
calcein/ethidhium positive staining and Image J software (Figure III-3). The results showed a high 
amount of living cells and low amount of dead cells.  
Among day 1 and 3 no significant differences occurred which can be explained with the 
natural lag-phase of cells after seeding into a new environment. At 7 days of culture, a vast area 
(      of surface was already covered and the cell number increase with the increase of culture 
time which is characteristic of the exponential growth phase of cells. Furthermore, between 
14 days and 21 days no differences were achieved in cell proliferation, cells reached the 
confluence. The results showed no cytotoxic effects from the film and an increase in cell number. 
Consequently, CHT and CS were used as polyelectrolytes for the fabrication of the 3D 
nanostructure. 
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Figure III-3: Percentage of surface area coverage with cells at 1, 3, 7, 14 and 21 days of culture. 
Significant differences for p<0.01(**) were found. 
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III-4.3.  Nanostructured Scaffolds: Physicochemical characterization 
III-4.3.1. Scaffold preparation and morphology 
The use of bottom-up approaches to produce 3D porous structures is particular relevant due 
to the hierarchical organization of the native tissues. It has been hypothesized that an 
interconnected 3D porous structure could be prepared combining LbL with leaching of free-packet 
paraffin spheres. A dropwise addition method of PEMS over the 3D template formed by free-packet 
paraffin spheres was applied. This technique allows the formation of a 3D lattice arrangement from 
a randomly placed paraffin spheres. After the coating the paraffin template was leached out and 
void spaces were created. Thus, the remaining material should be entirely composed by the 
CHT/CS multilayers - see Figure III-4-A. 
The morphology of the obtained scaffolds after the leaching was seen by optical microscopy. 
The results clearly reveal a soap-bubble-like morphology with geometry and pore sizes consistent 
with the paraffin spheres used as the template – see Figure III-4B. The interconnectivity should be 
assured by the existence of physical contact points between the neighbouring paraffin beads that 
will result in a passage point between the two pores after the leaching process (see red arrow in 
Figure III-4A). Further structural information was obtained by SEM - see Figure III-4-C. SEM images 
of freeze-dried scaffolds revealed a noticeable hollow imprint of the porous spherical wax template 
morphology. This concept allows the production of highly porous structure with controlled pore size 
and interconnectivity. Consequently, this type of scaffolds should allow the diffusion of substances 
as well as the integration of cells, namely its infiltration, migration and distribution in the entire 
volume of the scaffold. The histological cross-sections of the freeze-dried scaffold stained by alcian 
blue (Figure III 4-D) and eosin (Figure III 4-E) showed a homogeneous distribution of the 
polysaccharides. Moreover the size of the pores is again consistent with the paraffin template used. 
Alcian blue stained chondroitin sulphate [31] and eosin chitosan due to the high ability of this 
polysaccharide to adsorb anionic dyes [32]. 
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Figure III-4: Scaffold characterization: A) Production steps of scaffolds: LbL and leaching of free-
packet paraffin spheres, B) Optical Microscopy image of the scaffolds after the 
leaching of the core material, C) SEM micrographs of cross-sections (two different 
magnifications) and Histological cross-sections of the scaffolds after staining with 
alcian blue (E) and eosin (D). 
III-4.3.2. Fourier transform infrared spectroscopy 
FTIR measurements (Figure III-5A) were performed on the scaffold produced, as well as on 
both CHT and CS powders in order to identify the presence of both polysaccharides in the entire 
scaffold. The spectra of CHT and CS are very similar, as expected, reflecting the similarities in the 
chemical structure of both materials. As a result, they share some common peaks near around 
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3400 cm-1 corresponding to –OH and N-H bond stretching vibrations, and the peaks around 
2900 cm-1 corresponding to C-H stretching. Between 1020 cm-1 and 1080 cm-1 the peaks 
associated with the stretching of C-O bonds could be also observed. Moreover, the amide groups 
appeared at 1648 cm-1 [33, 34]. 
In the CHT spectrum the amine group bonds, characteristic of this polysaccharide, appeared 
at 1570 cm-1 [35] The representative peak of chondroitin sulphate was detected at 1250 cm-1 
corresponding to the stretching in the S=O bond (   
  ) [33, 34]. The spectrum of the scaffold 
shows globally the absorption peaks arising from both CHT and CS which is indicative of the 
presence of both raw materials in the final structure. 
  
 
Figure III-5: Physicochemical characterization of scaffolds: A) FTIR measurements of CHT/CS 
scaffolds and pure polysaccharides (CHT and CS), B) Swelling test up to 3 days (The 
inset graphic expands the water uptake for the first 5 hours), C) Weight loss of the 
scaffolds in PBS (▲) and in an enzymatic solution at 37°C (■). 
4500 4000 3500 3000 2500 2000 1500 1000 500
1
5
7
0
T
ra
n
s
m
it
a
n
c
e
 (
%
)
Wavenumber (cm
-1
)
 Chitosan
 Chondroitin sulfate
 Scaffold
A
1
2
5
0
0 10 20 30 40 50 60 70 80
0
50
100
150
200
250
300
W
a
te
r 
u
p
ta
k
e
 (
%
)
Time (h)
B
0 1 2 3 4 5
0
50
100
150
200
250
300
350
W
a
te
r 
u
p
ta
k
e
 (
%
)
Time (h)
0 2 4 6 8 10 12 14
0
5
10
15
20
25
30
35
40
45
50
W
e
ig
h
t 
lo
s
s
 (
%
)
Time (days)
 Enzymatic Sol.
 Control (PBS)
C
Chapter III – Nanostructured 3D constructs based on chitosan and chondroitin sulphate multilayers 
for cartilage tissue engineering 
 
64 
III-4.3.3. Swelling ability 
Water uptake is particularly important for implantable materials because it allows the diffusion 
and exchange of nutrients and waste to the entire scaffold; moreover water uptake ability also 
influence the mechanical performance of the biomaterial [8]. The materials used in the scaffold 
have abundant number of hydrophilic groups, such as hydroxyl, amino, sulphate and carboxyl 
groups, which can promote the swollen state of the scaffold [36]. The swelling ability was evaluated 
by soaking scaffolds in PBS (pH=7.4) at 37°C for 3 days – see Figure III-5B. The results showed 
that the water uptake increase mainly in the first hour and then tends to remain stable, reaching 
the equilibrium after 5 h (water uptake=280 %). This results can be explained due to the existence 
of hydrophilic groups, mainly hydroxyl groups, but mostly to CS charge, as a result of the fully 
ionization of its diprotic anionic functional groups, carboxyl groups (–COOH) and sulphate groups 
(   
  ) under neutral or low ionic strength media [37, 38]. The high density of charge increases 
the difference in osmotic pressure between the scaffold network and medium resulting in a swollen 
scaffold. 
III-4.3.4. Enzymatic degradation 
The biodegradability profile of scaffolds will dictate the changes of many properties of the 
structure that will occur upon the implantation. Enzymatic activity plays a fundamental role in the 
degradation of polysaccharides in vivo [39]. In vitro enzymatic degradation tests were performed 
with lysozyme and hyaluronidase solution and compared with weight loss in PBS (control). These 
two enzymes were chosen because they are present in the synovial fluid and they have as well the 
ability to cleave the polysaccharides used in this study [40, 41]. Lysozyme is able to degrade CHT 
and hyaluronidase has also the ability to degrade both CHT and CS [41-44]. The weight loss as a 
function of time is presented in Figure III-5C. 
The results showed that the scaffolds are degradable in the presence of the selected enzymes, 
showing weight losses of ca. 40 % after 14 days. The degradation of scaffolds in the presence of 
enzymatic solution is facilitated by the high porosity and interconnectivity of the structures allowing 
the easy access of the enzyme to their substrate. Moreover, the high hidrophilicity of CS (revealed by 
the high water uptake) can increase the interaction of scaffolds with the enzymatic solution, 
promoting the weight loss. The scaffolds placed in PBS also suffer some weight loss ca. 15 % after 14 
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days. In this case the weight loss may be the result of some disaggregation of the multilayered 
structure, as the polyelectrolytes are self-assembled through electrostatic interactions. The ions 
present in PBS may interact to the structure and promote partial detachment between the 
macromolecules resulting in their release to the medium. 
III-4.3.5. Mechanical Properties 
The viscoelastic/mechanical properties of an implantable device are fundamental for its 
performance in vivo [21]. Dynamical mechanical analysis (DMA) is an adequate non-destructive 
tool to characterize the mechanical and viscoelastic properties of polymeric materials [45, 46]. 
Since articular cartilage often bears a dynamic compression force, DMA experiments performed in 
a hydrated environment and at 37°C allow the assessment of scaffolds in more realistic conditions 
[21]. The storage modulus (E’) and loss factor (tan δ) as a function of frequency of the developed 
scaffolds, in the dry and wet state are presented in Figure III-6. The results for the hydrated scaffold 
showed a slightly increase in both E’ and tan δ with increasing frequency. In the dry state the 
values of E’ are about one order of magnitude higher when compared with the wet state. Such 
result is consistent with the high water uptake ability of the scaffolds and the plasticization effect of 
water molecules in such kind of polysaccharides that increases their molecular mobility and 
decreases the stiffness of the material. A similar loss of the stiffness due to the effect of water was 
observed in CHT membranes [47]. In both cases no evident variation of E’ along the frequency axis 
are seen, indicating that no relaxation phenomena takes place in the scaffolds within the time scale 
covered by the experiments. The tan δ of the dry sample decreases slightly with an increasing of 
frequency. However an opposite trend was observed when the samples were immersed in PBS. 
tan δ is higher in the wet samples, indicating that some dragging of entrapped water can 
participate in energy loss for the hydrated structure [48]. The DMA results demonstrated a 
viscoelastic behaviour of the scaffold which is particularly relevant for cartilage TE approaches 
owing to the viscoelastic nature of this tissue [49]. Moreover, the E’ values obtained are similar to 
ones of the mandibular condylar cartilage which ranges from 0.1 MPa to almost 1.5 MPa in the 
range of 0.01 – 10 Hz [50]. 
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Figure III-6: Variations of (A) Storage modulus (E’) and (b) loss factor (tanδ) of the CHT/CS 
scaffolds obtained by LbL methodology. Experiments are reported for dry samples (■) 
and hydrated samples in PBS at 37°C (●). 
III-4.4. Cells behaviour in nanostructured scaffolds 
III-4.4.1. Cell viability and adhesion\morphology 
The cell viability tests with bch (Figure III-7 A, D, G and J) showed a large amount of live cells 
(green) and almost no dead cells (red), consistent with the results obtained in the flat surfaces 
indicate, these results indicate that the scaffolds have also no cytotoxic effects to bch cells. After 
1 day it is possible to see that the cells tend to aggregate. Furthermore, the results obtained with 
MTT assay (Figure III-7 B, E, H and K) suggest an increase in cell number and metabolic due to the 
increase in dark purple staining over time. The results of live/dead assay for hMSCs (Figure III-8 A, 
D, G and J) also show low amount of dead cells, which indicate the absence of cytotoxic effects 
also for these types of cells. MTT results (Figure III-8 B, E, H and K) also shown metabolically 
active cells represented by the dark purple formazan precipitate, evidencing also an increase in the 
staining intensity with increasing time culture. 
Cell adhesion and morphology was further studied by SEM – see Figure III-7 C, F, I and L. The 
results obtained for bch at day 1 showed that cells were attached to the surface, displaying a round 
shape. After 3 days of culture the adherent cells might start the deposition of their own ECM which 
leads to further and faster cell spreading in the following time points. It was also possible to verify 
that some cell agglomeration occurred after 3 days inside the scaffold. In the latest time point the 
cells are more adhered and an increase in ECM deposition occurred. The bch presented a round 
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shape in all time points which is an indication of phenotype retention and essential for matrix 
deposition [51]. The results for hMSCs (Figure III-8 C, F, I and L) revealed that the cells were 
attached to the surfaces and presented a more stretched morphology. After 1 day, cells started to 
adhere and an increase in ECM deposition occurred in the inner areas of the scaffolds (t=14 days).  
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Figure III-7: Live/dead assay, MTT assay and cross-section SEM micrographs of Bch seeded on 
scaffold at day 1(A, B, C), 3(D, E, F), 14 (G, H, I) and 21(J, K, L) of culture in 
proliferation medium. 
 
 
1 mm 
1 mm 
1 mm 
1 mm 
C 
20 μm 
20 μm 
20 μm 
I 
L 
20 μm 
F 
Chapter III – Nanostructured 3D constructs based on chitosan and chondroitin sulphate multilayers 
for cartilage tissue engineering 
 
68 
 Live Dead MTT SEM 
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Figure III-8: Live/dead assay, MTT assay and cross-section SEM micrographs of HMSCs seeded on 
scaffold at day 1(A, B, C), 3(D, E, F), 14 (G, H, I) and 21(J, K, L) of culture in 
proliferation medium.  
III-4.4.2. Cell proliferation 
Cell proliferation in differentiation medium was evaluated using DNA assay (Figure III-9). The 
result obtained for the two types of cell showed that the number of both types of cells increased 
with increasing culture time. Between the first day of culture and after 35 days there were 
significant differences in the content of bch and hMSCs cells, indicating that the cells continue the 
1 mm 
1 mm 
1 mm 
1 mm 
C 
F 
 
I 
L 
20 μm 
20 μm 
20 μm 
20 μm 
Chapter III – Nanostructured 3D constructs based on chitosan and chondroitin sulphate multilayers for 
cartilage tissue engineering 
 
69 
proliferation even after long time culture. Thus, it is possible that new cells might migrate and 
populate areas of the scaffold in outside the regions of initial cell seeding. 
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Figure III-9: DNA assay on the scaffolds seeded with bch and hMSCs in differentiation medium. 
Significant differences between each cell type at different time points were found for 
p 0.05(*) and p<0.01(**). 
III-4.5. Histology 
Cell distribution and matrix production in differentiation medium was evaluated using histology 
cross-sections stained with H&E and alcian blue (Figure III-10, Figure III-11). 
The H&E staining of scaffold seeded with bch showed the round morphology of cells. 
Moreover, the abundance of cells per section is increased, which indicates again the occurrence of 
cell proliferation. At day 1, cells start to attach to the walls forming small aggregates. At day 14 the 
size of bch agglomerates increased. During the followed weeks, the cells presented a higher 
dispersion and distribution in the scaffolds. Sulphated GAGs, indicating new cartilage matrix 
formation, were stained by alcian blue. CS, which gives as well a positive staining for GAGs, can be 
distinguished from newly deposited matrix by comparing alcian blue staining at day 1 with later 
times. Secretion of GAGs by bch was seen at 14 days of culture. GAGs production increased during 
subsequent weeks. Lacunae formation was also seen in the matrix surrounding bch, namely at day 
21 and 35. The maintenance of chondrogenic phenotype is indicated by the round shape of the 
cells by the matrix production. 
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The scaffolds seeded with hMSCs were also stained with H&E. At day 1 it is possible to see 
some agglomerate cells and after 2 weeks the size of this agglomerates increased. During the 
following times of in vitro culture the hMSCs were more spread out throughout the scaffold. The 
GAGs secretion was also assessed and at day 14 a small amount of secretion could be seen. The 
amount of secretion increased during the next weeks. The secretion of GAGs by hMSCs indicates 
the chondrogenic differentiation of these cells. The driving force for differentiation in this assay 
have been TGF-β , however CS might also has a positive influence on chondrogenic differentiation , 
as reported before [31]. 
 
Figure III-10: Histological cross-sections of scaffolds seeded with bch stained by H&E and Alcian 
blue at different days of culture in differentiation medium. 
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Figure III-11: Histological cross-sections of scaffolds seeded with hMSCs stained by H&E and Alcian 
blue at different days of culture in differentiation medium. 
III-5. CONCLUSION 
Flat CHT/CS PEMs prepared using LbL did not elicit any cytotoxic effects to bch cells. It was 
possible to use LbL combined with spherical template leaching to produce CHT/CS 3D structures 
with high porosity and interconnectivity, just composed by self-assembled multilayers of these 
polyelectrolytes. Both bch and hMSCs could adhere and proliferate in these scaffolds, 
demonstrating the potential of their use in cartilage TE. Production of cartilage matrix production 
was observed upon culture in chondrogenic differentiation medium indicating that chondrogenic 
phenotype was maintained and hMSCs differentiation. Our results suggest that the nanostructured 
scaffolds of chitosan and chondroitin sulphate could have potential use in TE approaches for 
cartilage. 
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Chapter IV 
Chapter IV -  General Conclusion and Future Perspectives 
The objective of this dissertation was the development and characterization of 2D and 3D 
structures based on LbL methodology. Porous 3D structures can be useful for cartilage TE 
approaches. To accomplish this aim, two polyelectrolytes were selected: CHT and chondroitin CS. 
Herein a summary of major achievements will be given. 
IV-1. GENERAL CONCLUSIONS 
A novel type of nanostructured scaffolds based on CHT and CS was obtained, combining LbL 
and leaching of spherical templates. The potential of these structures for cartilage TE was 
evaluated. 
For the proof of concept, biological assays were first performed in multilayer surfaces with 
bovine chondrocytes (bch) and no cytotoxic effects of the film were found. Thus, PEMs was 
transposed to 3D level and originated a structure with a soap-bubble-like morphology, as proven by 
optical microscopy after the leaching of the all core material. Moreover, the scaffolds present a 
high porosity and interconnectivity, owning to the leaching of all the paraffin and physical contact 
points between the original paraffin beads. After the freeze drying, SEM images revealed a 
noticeable hollow imprint of the porous spherical wax templates geometry. The histological cross-
sections of the freeze dried scaffolds showed a pore size consistent with the paraffin template and 
a homogeneous distribution of the both polysaccharides, as proven with FTIR.  
Swelling test and enzymatic degradation demonstrated a structure with ability to diffuse 
substances and gradual degradation. Mechanical tests performed with DMA revealed the 
viscoelastic properties of the scaffolds which corroborate the results obtained at QCM (an increase 
of dissipation (ΔD) in each polyelectrolyte injection).  
The applicability of the nanostructured scaffold for cartilage TE approaches was evaluated in 
cellular assays with bch and human mesenchymal stem cells (hMSCs). The cells were viable, 
metabolically active and proliferate during 35 days of in vitro studies, as live dead/MTT assay, SEM 
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analysis and DNA quantification showed. Histological cross-sections revealed the maintenance of 
chondrocyte phenotype and chondogenic differentiation of hMSCs. The physicochemical and 
biological advantages presented in this study will make it probably possible to apply the current 
scaffolds to cartilaginous lesions. 
IV-2. FUTURE PERSPECTIVES 
A number of valuable results were obtained in this research project which will hopefully be of 
utility in future investigations. The usefulness of nanostructured 3D constructs based on CHT and 
CS multilayers for cartilage TE approaches are the most significant contributions of this thesis. The 
next steps may include the following studies: 
 
1. The production of structures with gradients of porosity, using different size of paraffin wax 
spheres; 
 
2. Increase the mechanical properties of the constructs using for that a high number of 
layers, crosslinking or fillers; 
 
3. Evaluate the behaviour of cells with different number of layers; 
 
4. Assess gene expression with polymeric chain reaction (PCR); 
 
5. Study the effect of chondroitin sulphate in chondrogenic differentiation. 
 
 
